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ABSTRACT 
Leishmaniasis is a threat to almost one fourth of the 
world's population. It is a major health problem in tropical 
countries. Millions of cases occur each year in the tropics 
and almost about one million children die of leishmaniasis in 
India alone. The development of successful leishmania 
vaccine is considered as supplementary to the existing 
chemotherapy which will ultimately depend on the availability 
of safe and effective adjuvants. 
BHMARB medium was used for axenic culture of Leishmania 
donovani promastigotes. It was found to adequately support 
the growth of the parasite. The rate of multiplication of 
promastigotes in BHMARB medium was about 379.31 times after 6 
days of incubation. Promastigotes obtained from 6 day old 
cultures in BHMARB medium w^re washed 6 times in normal 
saline to which gentamycin was added. The washed 
promastigotes were dispensed by shaking and osmolysed in 
double distilled water. The osmolysed suspension represented 
the whole antigen preparation from L. donovani promastigotes. 
The soluble and particulate antigen fractions were obtained 
by centrifugation of the whole antigen at 105,000 x g for one 
hour. The supernatant thus obtained represented the soluble 
antigen fraction, while the deposit represented the 
particulate antigen fraction. 
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The various leishmanial antigen fractions were 
partially characterized by estimating protein, carbohydrate, 
DNA contents and antigenicity before being used for 
immunization studies. SDS-PAGE was carried out for separation 
of protein sub-units of each antigen fraction and also for 
the determination of molecular weights. The antigenicity of 
whole antigen soluble and particulate antigen fractions was 
checked against antisera obtained from cases of Kala-azar. 
Indirect haemagglutination (IHA) and agar diffusion tests 
were employed to detect the antigenic activity of whole 
antigen, soluble and particulate antigen fractions. An 
antigen dilution of 1:16 was found to be the optimum working 
dilution for use in IHA tests. 
Golden hamsters which are highly susceptible to L. 
donovani infection were used for different immunization 
experiments. In the first experiment, the animals were 
inoculated with whole antigen, soluble and particulate 
antigen fractions alone. In the second experiment the animals 
were similarly inoculated with various antigen fractions in 
combination with muramyl dipeptide (MDP) as an adjuvant. 
Animals in control groups in each set of experiments received 
either saline or muramyl dipeptide. Each hamster was 
« 
inoculated intraperitoneally with four injections, each dose 
containing 0.2 mg antigen with or without MDP (450 /ig) at 4 
day intervals. 
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Humoral immune responses were detected in different 
experimental groups of golden hamsters immunized with whole, 
soluble and particulate antigen fractions only and then in 
combination with MDP. The sera samples obtained from 
different groups of immunizing animals were tested for the 
presence of anti-leishmania antibodies by means of Indirect 
haemagglutination test (IHA) and Enzyme linked immuno sorbent 
assay (ELISA). The highest reciprocal antibody titres in both 
the tests was found to be maximum in the sixth week after the 
last immunizing dose. Animals immunized with parasite 
antigens in combination with MDP showed titre values greater 
than those which received parasite antigen alone. In IHA 
test, animals immunized with whole antigen and MOP showed 
the highest reciprocal titre value of 512 in the 6th week 
after immunization. Reciprocal titre value was 256 in animals 
immunized with particulate antigen and MDP in the 6th week. 
In ELISA, serum samples from animals immunized with whole 
antigen and MDP showed a highest reciprocal titre value of 
1024 in the sixth week after immunization. This was followed 
by a reciprocal titre value of 1024 in the animals immunized 
with particulate antigen and MDP in the fourth week after the 
last immunizing dose and similarly the reciprocal titre value 
was 256 in animals immunized with soluble antigen and MDP in 
the sixth week following challenge. The appearance of Cell-
mediated immunity in experimental animals was demonstrated by 
development of delayed type hypersensitivity response (DTH). 
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The DTH response manifested as footpad swelling following the 
administration of phenol suspended promastigotes was negative 
in all the groups receiving whole, soluble and particulate 
antigen fractions, alone and in combination with MDP. The 
animals were tested in the second, fourth and sixth week 
following the last immunizing injection. Animals which 
received parasite antigen and MDP showed leukocytosis, while 
animals which received parasite antigens only showed normal 
total leukocyte counts compared to control animals. The 
percentage of polymorphonuclear cells was higher in the 
antigen - MDP groups than in the antigen groups. 
All the immunized animals were subsequently challenged 
by intraperitoneal injection of viable L. donovani 
promastigotes. Each animal received challenge dose containing 
1 ml of 1 X 10^  promastigotes. Following challenge, serum 
samples obtained from the ch^iHenged animals were employed 
for the detection of humoral immune response of L. donovani 
specific antibodies by means of IHA and ELISA tests. Animals 
which received antigen-MDP combinations showed higher 
antibody titres than those given antigens only. Animals 
immunized with whole antigen and MDP showed the highest 
reciprocal titre values ih the sixth week after the 
challenge. The DTH was positive only in animals which 
received parasite anitgens in combination with MDP. The 
increased foot pad swelling was recorded in animals immunized 
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with whole antigen in combination with MDP. Ce11-mediated 
immune response was also assessed, in vitro, by macrophage 
migration inhibition test. Highest percentage of migration 
inhibition values were obtained from animals which received 
whole antigen in combination with MDP. The antigen -MDP 
groups showed higher TLC with slight increase in lymphocyte 
and monocyte counts. The control animals and those which 
received parasite antigens only showed leukopenia accompanied 
with lymphocytosis and slight increase in monocytes. 
Parasitaemia and footpad lesions were developed only in 
control animals but not in immunized animals. 
Animals which received parasite antigen in combination 
with MDP showed significantly reduced parasite burden both 
in the splenic and hepatic counts after the challenge. This 
was in total contrast to animals which were given parasite 
antigens only, where no such reduction was observed. Animals 
receiving whole antigen in combination with MDP showed 
significant reduction in the splenic and hepatic parasite 
count in the post challenge period. Histopathology of liver 
and spleen from control animals revealed specific tissue 
reaction to leishmania infection consisting of endothelial 
proliferation and granuloma formation. There were moderate 
number of L.D. bodies in the hyperplased macrophages. These 
reactions increased with the progress of infection leading to 
distortion of liver and splenic architectures. 
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similar changes, though to a lesser extent, were 
observed in animals which were immunized with parasite 
antigens only. The liver and spleen architecture in the 
antigen - MDP immunized groups showed very minor changes or 
alterations. Some fibrous reactions were obvious in the 
spleen, but the L.D. bodies were rarely seen in the 
hyperplased macrophages. These studies have clearly shown 
that protection can be elicited in golden hamsters against L. 
donovani infection by immunizing the animals with whole 
antigen in combination with MDP as an adjuvant such an immune 
protection was evident by lower parasite burdens in liver and 
spleen in of immunized animals positive DTH, high TLC and 
almost normal liver and splenic architectures compared to 
control animals. However, hamster immunized with particulate 
antigen in comibnation with MDP, showed lesser degree of 
resistance against infection. The souble antigen fraction was 
also found to be immunogenic to certain extent when used in 
combination with MDP. 
Thus, based on the knowledge generated on the 
immunology of leishmaniasis, it is becoming evident that a 
leshmania vaccine adjuvant must be capable of inducing both 
humoral and cell mediated immune responses. Our composite 
observation thus provide evidence for MDP-enhanced non-
specific resistance of hamsters to visceral leishmaniasis. 
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ABSTRACT 
ABSTRACT 
Leishmaniasis is a threat to almost one fourth of the 
world's population. It is a major health problem in tropical 
countries. Millions of cases occur each year in the tropics 
and almost about one million children die of leishmaniasis in 
India alone. The development of successful leishmania 
vaccine is considered as supplementary to the existing 
chemotherapy which will ultimately depend on the availability 
of safe and effective adjuvants. 
BHMARB medium was used for axenic culture of Leishmania 
donovani promastigotes. It was found to adequately support 
the growth of the parasite. The rate of multiplication of 
promastigotes in BHMARB medium was about 379.31 times after 6 
days of incubation. Promastigotes obtained from 6 day old 
cultures in BHMARB medium were washed 6 times in normal 
saline to which gentamycin was added. The washed 
promastigotes were dispensed by shaking and osmolysed in 
double distilled water. The osmolysed suspension represented 
the whole antigen preparation from L. donovani promastigotes. 
The soluble and particulate antigen fractions were obtained 
by centrifugation of the whole antigen at 105,000 x g for one 
hour. The supernatant thus obtained represented the soluble 
antigen fraction, while the deposit represented the 
particulate antigen fraction. 
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The various leishmanial antigen fractions were 
partially characterized by estimating protein, carbohydrate, 
DNA contents and antigenicity before being used for 
immunization studies. SDS-PAGE was carried out for separation 
of protein sub-units of each antigen fraction and also for 
the determination of molecular weights. The antigenicity of 
whole antigen soluble and particulate antigen fractions was 
checked against antisera obtained from cases of Kala-azar. 
Indirect haemagglutination (IHA) and agar diffusion tests 
were employed to detect the antigenic activity of whole 
antigen, soluble and particulate antigen fractions. An 
antigen dilution of 1:16 was found to be the optimum working 
dilution for use in IHA tests. 
Golden hamsters which are highly susceptible to L. 
donovani infection were used for different immunization 
experiments. In the first experiment, the animals were 
inoculated with whole antigen, soluble and particulate 
antigen fractions alone. In the second experiment the animals 
were similarly inoculated with various antigen fractions in 
combination with muramyl dipeptide (MDP) as an adjuvant. 
Animals in control groups in each set of experiments received 
either saline or muramyl dipeptide. Each hamster was 
inoculated intraperitoneally with four injections, each dose 
containing 0.2 mg antigen with or without MDP (450 /xg) at 4 
day intervals, 
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Humoral immune responses were detected in different 
experimental groups of golden hamsters immunized with whole, 
soluble and particulate antigen fractions only and then in 
combination with MDP. The sera samples obtained from 
different groups of immunizing animals were tested for the 
presence of anti-leishmania antibodies by means of Indirect 
haemagglutination test (IHA) and Enzyme linked immuno sorbent 
assay (ELISA). The highest reciprocal antibody titres in both 
the tests was found to be maximum in the sixth week after the 
last immunizing dose. Animals immunized with parasite 
antigens in combination with MDP showed titre values greater 
than those which received parasite antigen alone. In IHA 
test, animals immunized with whole antigen and MDP showed 
the highest reciprocal titre value of 512 in the 6th week 
after immunization. Reciprocal titre value was 256 in animals 
immunized with particulate antigen and MDP in the 6th week. 
In ELISA, serum samples from animals immunized with whole 
antigen and MDP showed a highest reciprocal titre value of 
1024 in the sixth week after immunization. This was followed 
by a reciprocal titre value of 1024 in the animals immunized 
with particulate antigen and MDP in the fourth week after the 
last immunizing dose and similarly the reciprocal titre value 
was 256 in animals immunized with soluble antigen and MDP in 
the sixth week following challenge. The appearance of Cell-
mediated immunity in experimental animals was demonstrated by 
development of delayed type hypersensitivity response (DTH). 
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The DTH response manifested as footpad swelling following the 
administration of phenol suspended promastigotes was negative 
in all the groups receiving whole, soluble and particulate 
antigen fractions, alone and in combination with MDP. The 
animals were tested in the second, fourth and sixth week 
following the last immunizing injection. Animals which 
received parasite antigen and MDP showed leukocytosis, while 
animals which received parasite antigens only showed normal 
total leukocyte counts compared to control animals. The 
percentage of polymorphonuclear cells was higher in the 
antigen - MDP groups than in the antigen groups. 
All the immunized animals were subsequently challenged 
by intraperitoneal injection of viable L. donovani 
promastigotes. Each animal received challenge dose containing 
1 ml of 1 X 10^ promastigotes. Following challenge, serum 
samples obtained from the challenged animals were employed 
for the detection of humoral immune response of L. donovani 
specific antibodies by means of IHA and ELISA tests. Animals 
which received antigen-MDP combinations showed higher 
antibody titres than those given antigens only. Animals 
immunized with whole antigen and MDP showed the highest 
reciprocal titre values in the sixth week after the 
challenge. The DTH was positive only in animals which 
received parasite anitgens in combination with MDP. The 
increased foot pad swelling was recorded in animals immunized 
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with whole antigen in combination with MDP. Cel1-mediated 
immune response was also assessed, in vitro, by macrophage 
migration inhibition test. Highest percentage of migration 
inhibition values were obtained from animals which received 
whole antigen in combination with MDP. The antigen -MDP 
groups showed higher TLC with slight increase in lymphocyte 
and monocyte counts. The control animals and those which 
received parasite antigens only showed leukopenia accompanied 
with lymphocytosis and slight increase in monocytes. 
Parasitaemia and footpad lesions were developed only in 
control animals but not in immunized animals. 
Animals which received parasite antigen in combination 
with MDP showed significantly reduced parasite burden both 
in the splenic and hepatic counts after the challenge. This 
was in total contrast to animals which were given parasite 
antigens only, where no such reduction was observed. Animals 
receiving whole antigen in combination with MDP showed 
significant reduction in the splenic and hepatic parasite 
count in the post challenge period. Histopathology of liver 
and spleen from control animals revealed specific tissue 
reaction to leishmania infection consisting of endothelial 
proliferation and granuloma formation. There were moderate 
number of L.D. bodies in the hyperplased macrophages. These 
reactions increased with the progress of infection leading to 
distortion of liver and splenic architectures. 
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Similar changes, though to a lesser extent, were 
observed in animals which were immunized with parasite 
antigens only. The liver and spleen architecture in the 
antigen - MDP immunized groups showed very minor changes or 
alterations. Some fibrous reactions were obvious in the 
spleen, but the L.D. bodies were rarely seen in the 
hyperplased macrophages. These studies have clearly shown 
that protection can be elicited in golden hamsters against L. 
donovani infection by immunizing the animals with whole 
antigen in combination with MDP as an adjuvant such an immune 
protection was evident by lower parasite burdens in liver and 
spleen in of immunized animals positive DTH, high TLC and 
almost normal liver and splenic architectures compared to 
control animals. However, hamster immunized with particulate 
antigen in comibnation with MDP, showed lesser degree of 
resistance against infection. The souble antigen fraction was 
also found to be immunogenic to certain extent when used in 
combination with MDP. 
Thus, based on the knowledge generated on the 
immunology of leishmaniasis, it is becoming evident that a 
leshmania vaccine adjuvant must be capable of inducing both 
humoral and cell mediated immune responses. Our composite 
observation thus provide evidence for MDP-enhanced non-
specific resistance of hamsters to visceral leishmaniasis. 
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INTRODUCTION 
INTRODUCTION 
1. HISTORY OF THE PARASITE 
The importance of human leishmanial infection has bejen 
fully realised only in recent years. In accordance with t,he 
goals of the W.H.O.'s. Tropical Diseases Research Programmte, 
visceral leishmaniasis has been given a high priority, only 
next to Malaria. 
The leishmanias are the causative agents of a varietty 
of human diseases termed "Leishmaniasis". Leishmania donovani 
is the etiologic agent of visceral leishmaniasis (Stauber, 
1970). About 400,000 new cases of disseminated leishmaniasis 
are reported almost every year from endemic areas of the 
World (Liason & Shaw, 1978). Although there is no 
quantitative evaluation at the moment but rough estimates 
based on extrapolations of the scarce data available indicate 
that some 350 million people in the world are at risk of 
acquiring leishmaniasis and that approximately 12 million are 
currently infected (WHO, Tech. Rep. Ser., 1990). The parasite 
exists in two forms, the promastigotes and amastigotes. The 
free swimming promastigotes enter a vertebrate host through 
the bite of an infected phlebotomine sandfly. These 
promostigotes then get themselves converted to amastigote 
forms which take up residence within the tissue macrophages 
of the host. The amastigotes divide and multiply in the liver 
and spleen tissues (Stauber, 1970). 
The human leishmaniasis was first reported by 
Cunningham in 1885, when he observed but misinterpreted the 
parasites in the tissues of a Delhi Boil in Calcutta. The 
organisms were mistaken as Mycobacteria. Later, in 1898 
Borovsky established the protozoan nature of the parasite 
(Zuckermann & Lainson, 1977). But it was leishman who first 
described this organism as a causative agent of visceral 
leishmaniasis in man. He made this discovery in India in 
1903. He also established its relationship to trypanosomes. 
It was first named as PiropTasma donovanic, but the name was 
later changed to Leishmania donavani by Ross in 1903. In the 
same year, Wright referred to the causative agent of oriental 
sore as Helcosoma tropica, while the name of L. tropica was 
first assigned by Luhe in 1906 (Zuckerman & Lainson, 1977). 
Rogers (1904) and Nicolle (1908a) established the 
trypanpsomatid nature of L. donovani and L. tropica 
parasites. The causative agent of infertile Kala-azar was 
named as L. infantum hy Nicolle (1908a). It is more commonly 
found in the Mediterranian countries, as also in other parts 
of Asia, Europe and Africa. Yakimoff and Schochov in 1915 
described L. tropica major as the causative agent of 
Zoonotic cutaneous leishmaniasis (Zuckerman & Lainson, 1977). 
Bray et a7. (1973) established the name L. aethiopica for the 
parasite causing cutaneous, as well as more diffused 
cutaneous leishmaniasis in Ethopia and Kenya. 
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In 1948 Muniz and Medina discovered L. enviettii in 
guinea pigs in Panama State and Brazil. Biagi in 1S53 and 
Floch in 1954 referred to L. tropica mexicana as the 
causative agent of Chiclevo's ulcer in British Handouras, 
Gutaemala and Yucatan, while they held L. tropica 
brazilienses and L. tropic quvanesis responsible for causing 
mucocutaneous leishmaniasis in Brazil and cutaneous 
leishmaniasis in Panama and Costa Rica; respectively 
(Zuckerman and Lainson, 1977). Lainson and Shaw (1972) 
classified leishmaniasis into two major groups, the L. 
mexicana and L. brazi liensis complexes. 
2. Taxonomy 
The various causal agents of leishmaniasis belong to 
the genus Leishmania whose systematic position is as follows: 
(W.H.O. - TDR / LEISH - SEM/ 80.3) 
Phylum - Protozoa 
Subphylum - Sarcomastigophora 
Order - Kinetoplastida 
Sub order - Trypanosomatina 
Family - Trypanosomatidae 
Genus - Leishmania 
The genus Leishmania has a wide distribution in the 
tropics and subtropics, but is apparently absent in Sout-East 
Asia and the Pacific. 
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3. Clinical Forms 
Leishmaniasis, the disease caused by the infection of 
flagellate prtozoan parasite, Leishmania, occur in three 
major clinical forms, visceral, mucocutaneous and cutaneous. 
I. Visceral Leishmaniasis (VL) 
Visceral leishmaniasis or Kala-azar is a clinical 
condition manifesting itself due to the infection of 
reticuloendothelial cells by Leishmania donovani parasites. 
The resultant disease is characterized by a lengthy 
incubation period, an insidious onset and a chronic course 
attended by irregular fever, increasing enlargement of the 
spleen and liver, leucopenia, anemia and progressive wasting. 
The mortality is high, death occurs in untreated cases in 2 
months to 2 years. 
Post Kala-azar Dermal Leishmaniasis (PKDL) 
It is an important sequelae of Kala-azar found in 
India, China and Sudan. It develops when visceral infection 
persists for a year or so. The dermal lesions vary 
considerably in appearance. Sometimes the erythematous lesion 
which appears on the face may commonly assume a butterfly 
distribution over the nose and cheeks, while in others it may 
appear in the form of multiple hypopigmented macules which 
later on take the form of nodules. A large number of L. 
donovani can be recovered from such skin lesions. 
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II. Mucocutaneous Leishmaniasis (MCL) 
Mucocutaneous leishmaniasis or Espundia of South 
America is a clinical condition due to infection of 
reticuloendothelial cells, initially of the skin and 
subsequently of the mucosae of the mounth and nose following 
L. braziliensis infection. It is characterized by the 
appearance of a variety of skin lesions; a papular lesion 
commonly becomes nodular and then ulcerates. Sometimes 
metastatic lesions may develop in the mucosae of the upper 
respiratory tract and the mouth, which extensively erode the 
adjacent tissues. 
III. Cutaneous Leishmaniasis (CL) 
Cutaneous" Leishmaniasis is a clinical condition due to 
the infection of reticulo-endothel ial cells of the skin and 
in some cases also mucosa, following infection with L. 
tropica (Old world), L. mexicana and possibly L. braziliensis 
(New World). The resultant diseases are characterized by 
single or multiple indolent skin lesions and in some cases 
mucosal lesions without systemic involvement. The infection 
may .disappear spontaneously leaving disfiguring scars, or 
persist for very long period causing multilation. 
4. Geographical Distribution And Epidemiology 
I. Visceral Leishmaniasis (VL, Kala-azar) 
It is endemic in several parts of Africa, the Indian 
subcontient and Latin America. It occurs sporadically in 
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China, the Mediterranean Basin, South-West Asia and Southern 
parts of the Soviet Union. 
In 1977, an endemic of Kala-azar occurred in the state 
of Bihar, India, affecting 1,00,000 people (Survey Report of 
National Institute of Communicable Disease, India). For the 
following year in 1978 a conservative estimate of the 
infection was around 40,000 cases. 
II. Mucocutaneous Leishmaniasis (MCL) 
It is primarily found in South America, although cases 
have also been reported in Africa, notably Ethopia and Sudan. 
III. Cutaneous Leishmaniasis (CL) 
It is the most prevalent form of Leishmaniasis, found 
in Africa, Latin America, the Indian subcontinent, South-West 
Asia, and parts of the Mediterranean Basin and Soviet Union. 
Uncomplicated cutaneous lesions heal within nine months (in 
the Middle East) to two years (in Central and South America). 
However, non-healing lesions occur, as in diffuse cutaneous 
leishmaniasis (found in Ethopia), leishmaniasis Recidivans 
(in the Middle East) and Post Kala-azar Dermal leishmaniasis 
(in East Africa and India). 
Large scale epidemics as reported from India and China 
are unlikely to occur in Latin America, mainly due to a 
corresponding thinly distributed population. About 4,00,000 
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new cases of disseminated leishmaniasis are reported almost 
every year from endemic areas of World (Lainson and Shaw, 
1978). The recent situation with respect to Kala-azar 
infection in India indicates that this may very well be an 
underestimate. 
5. LIFE CYCLE AND MORPHOLOGY 
The life cycle of leishmaniasis can be described in two 
different stages, the intracellular amastigotes within the 
phagocytes of the reticuloendothelial system of the mammalian 
host (Dwyer, 1976; Chang and Dwyer, 1978); and extracellular 
promastigotes in the digestive tract of the sandfly vectors, 
Phlebotomus and Lutzomyia (Bray, 1974). 
The amastigote stage or L.D. body (Leishman Donovan 
body) is a small non-flagellated spherical or ovoidal body 
(2-4.5 Aim/ 1-2 >um) containing a central nucleus, a 
kinetoplast and a rudimentry non-functional flgellum 
(Zuckerman and Lainson, 1977; Chang, 1983). The L.D. bodies 
are found in the cells of the R.E. system, as also in other 
tissues. 
The promastigote stage found in the gut of sandfly 
vector is a motile body of variable dimension (about 2 um -
20 um) with flagellum running all along the body length. The 
kinetoplast is terminal or subterminal with a centrally 
located nucleus (Zuckerman & Lainson, 1977). Both amastigote 
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and promastigote forms multiply by binary fission. The 
promastigotes after multiplication in the midgut and hind 
gut migrate to the pharynx of the sandfly vector. 
When an infected sandfly bites a man, it inoculates 
promastigotes or leptomonad forms of the parasite which are 
engulfed by nearby macrophages in the skin. On entering the 
macrophages, the promostigotes metamorphose into amastigotes 
within the cytoplasm of the host cells. The amastigotes 
multiply slowly, while some of the parasitised macrophages 
are released and carried to the centre of reticuloendothelial 
activity such as liver, spleen, bone marrow etc. 
6. ULTRASTRUCTURE OF LEISHMANIA PARASITE 
There are two developmental stages in leishmanial the 
promastigote in the sandfly host and the amastigote in 
various species of mammals and reptiles. 
The promastigote is surrounded by a smooth trileuninate 
membrane 10-12 mm thick, underneath which lie the 
longitudinal microtubules that are linked to the inner 
membrane by fibrils. The distance between the microtubules 
may vary according to the species. 
The endoplasmic reticulum is poorly developed but bears 
osmiophilic granules resembling ribosomes. Cytoplasmic 
vacoules vary in size from 200 mm to 2 xjm; dense lipid 
inclusions also very in size. Volutin granules containing 
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acid-insoluble polyphosphates and RNA are found in old 
promastigotes. 
Large cristate mitochondrial sections are located near 
the nucleus and kinetoplast, and smaller sections are found 
throughout the cytoplasm. The Golgi apparatus, located 
between the nucleus and kinetoplast, has a distinctive 
structure. Lysosomes are produced at the mouth of densely 
packed cisternae. The Nucleus is bound by a double membrane 
with pores of 60-80 nm and contains granules and filaments in 
addition to the nucleolus. 
Reproduction starts with the division of the 
kinetoplast and blepharoplast. The kinetoplast lengthens, 
without change in structure, then divides. The details of the 
division of the blepharoplast are unknown, but the dividing 
cells has two b1epharop1asts: One at the base of the 
flagellum and one that develops later, apart from the 
flagellum. Division of the nucleus has been said to involve 
spindle formation. The structure of the nuclear membrane 
remains unchanged during division. 
The kinetoplast appears as a curved hollow bar, or 
horse shoe shape, containing longitutinal cristae attached 
to the posterior wall, and spirally coiled fibrils. The 
kinetroplast is Feulgen positive, indicating that it contains 
DNA, as it also contains glycogen. 
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The blepharoplast is anterior to the kinetroplast, at 
the base of the blepharoplast farthest from the flagellum, 
there are nine groups of three peripheral fibrils without 
central fibrils, the latter appearing only close to the 
flagellar base. 
The flagellum is bound by a continuation of the cell 
membrane and contains nine pairs of peripheral fibrils and 
the central fibrils. At the point of attachment of the 
flagellum is an invagination of the cell membrane, the 
flagellar pocket, which resembles a cytostome and where the 
ingestion of nutrients occurs. 
The ultrastructure of amastigotes generally resembles 
that of promastigotes, except for the overall shape and the 
absence of a free flagellum. 
7. LEISHMANIA ANTIGEN 
The antigens of greatest practical importance in 
leishmaniasis are those related to immunodiagnosis, 
immunopathology and protective immunity. Since these are 
molecules that are defined functionally (by eliciting an 
immune response), their analysis should also be closely 
integrated with functional studies. The identification of 
subcellular antigenic fractions of leishmania species and the 
differentiation of common as well as strain specific antigens 
help in determining suitable antigens which are capable of 
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eliciting protective immunity (Cook and Holbrook, 1983). 
Preston and Dumonde (1971) suggested that leiehmania may 
contain two types of antigen: those which stimulate specific 
resistance to infection (particulate antigen) and those which 
depress specific resistance to infection (soluble antigens). 
Cook et al (1969) reported that leishmania parasites 
constitute an antigenic mosaic. Clinton et. al . ( 1 972) 
demonstrated eleven antigens in a lysate of L. donovani. 
Relatively little is known of the antigenic similarities and 
differences between L. donovani promastigotes and amastigote 
developmental stages (Dwyer, 1973; Zukerman, 1975). 
Antibody cross absorption experiments showed that both 
promastigote and amastigote stages share some common or 
crossreacting surface membrane antigens. Each parasite form 
is known to contain unique stage - specific, surface membrane 
antigens (Dwyer, 1976). Along with these cross-reacting 
surface antigens, four antigens common to promastigote and 
amastigote forms are also known to exist. These antigens were 
detected in cell-free extracts of L. donovani (Simpson, 
1968; Ghatak et a/., 1982). Subcellular fractions of cell-
free extracts showed that the maximum amount of such common 
antigens is present in the souluble supernatant. These 
supernatants were found to contain three types of antigens 
distinguished on the basis of their thermostability. These 
antigens do not share antigenic relationship with 
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^cobacterium and blood group antigens (Ghatak et al., 19821. 
f-evious studies have shown a c ross-reac t i on betwean 
irishmania and other protozoans in immunological tesSs 
fertaresche et al., 1975; Roffi et a/., -1980). Such crces 
lactivity is also reported between leishmaniasis sera f0d 
i^cobacterial antigens (Smrkovski and Larson, 1977). 
Irfection with nonpathogenic or mildly pathogenic strains of 
'^cobacterium in normal humans and laboratory animals can 
laduce the formation of antibodies reactive with Leishmafita 
iS low serum dilutions (Allain and Kagan, 1975; Bardana «t 
1973). 
It was also reported that both promastigotes and 
atestigotes of L. donovani share antigens that cross-react 
iffth components of blood cells from normal individuals of 
all ABO system types (Decker-Jackson and Honigberg, 1978). 
Many antigens are shared between different species of 
leishmania as shown in immunofluorescent and ELISA tests 
(Cdrissian and Darabian, 1979). Strains of L. tropica^ L. 
donovani and L. brazi1iensis possess common antigens as 
shown by positive reactions in Kala-azar. This relationship 
does not extend as far as the appearance of cross immunity to 
Intradermal inoculation of cultures is concerned (Manson-
Bahr, 1961). Since cross reactivity between 7. cruzi and 
Leishmania species is well known in serological tests 
(Decker-Jackson and Honigberg, 1978), it was suggested that 
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extract from L. donovani chagasi promastigotes should be the 
antigen of choice for diagnosis or visceral leishmaniasis by 
means of IFA tests. These tests were considered more suitable 
for areas with known endemicity for trypanosomiasis (Badarlo 
et al., 1983). 
In an attempt to determine the role of T-lymphocytes 
and the nature of antigens that activate them, an antigen-
specific murine T-lymphocyte clone that proliferates in 
response to antigens present on the membrane of intact L. 
donovani promastigotes was propogated. One such line cross-
reacts with membrane antigens on seven other species and to 
a lesser extent with antigens on African Procyclic 
Trypanosomes. These antigens were found to contain both 
mannose and galactose ligands. The antigenic activity was 
also absorbed using extensively cores-reactive monoclonal 
antibodies to parasites (Sheppard et al. 1983). 
Surface antigens of L. donovani promastigote isolates 
have been extensively studied. Surface patterns of Brazilian 
and African isolates display remarkable similarities. These 
patterns appear simple, consisting of three major peptides of 
65,000, 25,000 and 23,000 molecular weight. These proteins 
were found common to all the strains as tested against sera 
from Kala-azar patients collected both from Brazil and 
Africa. Experiments to bind these peptides with concanavalin-
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A suggested the glycoproteinic nature of these antigens. Sera 
from patients with cutaneous leishmaniasis (L. brazi1iensis) 
also recognized this 65,000 molecular weight determinant, 
though to a lesser extent. This major surface antigen was 
suggested to be shared with minor differences, not only by L. 
donovani strains but by Leishmania species in general (Lepay 
et al 1983). The antigenic determinants of L. donovani 
promast i gotes were shown to be both of protein and 
polysaccharidic nature. A precipitating antigen of about 5.4 
X 10^ dalton molecular weight was purified from crude soluble 
antigen by biochemical techniques and was characterized as a 
glycoprotein with protein determinants. A polysaccharide rich 
antigen was also isolated from the parasite (Qhose and Roy, 
1983). In an early study, soluble antigenic substances 
liberated by amastigotes of L. donovani were shown to be 
present in the sera of infected dogs (Nattan-Larrier and 
Grimard-Richard, 1933). Adler and Gunders (1964) also 
demonstrated the release of 'exoantigens' by L. tropica and 
L. maxicana amastigotes and promastigotes. These exoantigens 
were able to elicit skin response in sensitized persons. This 
was confirmed by Sergeiev and Shuikina (1969) for L. tropica. 
Bray and Lainson (1966) found a soluble factor in the used 
medium for cultures of L. mexicana promastigotes. Similarly, 
Clinton et al. (1972) recognized, for the first time, the 
existence of a soluble factor in the used medium from 
cultures of L. donovani promastigotes. This excreted factor 
15 
(EF) was shown to be immunologically active in sensitized 
guinea pigs, as it produced a delayed skin reaction and was 
capable of precipitating anti-Leishmania antibodies raised 
in rabbit against living homologous promastigotes (Schnur et 
al, 1972). 
It was demonstrated that antigenic determinants are 
shared by promastigotes. Its excreted factor (EF), and the 
excreted factor from the homologous amastigotes, are 
serologically specific for individual Leishmanial strains. It 
is, therefore, possible to define Leishmanial serotypes with 
the aid of EF (Schnur et a7. 1972). The EF of L. mexicana 
was used as an antigen for coating wells for modified ELISA 
and sheep red cell agglutination assays. The ELISA as tested 
against sera of LD positive patients, was found much more 
sensitive than tanned red cell haemagglutination test (TRCH). 
The EF also showed some cross reaction against sera of 
patients with malaria and amoebiasis. Thus the crude EF of L. 
mexicana which can be obtained in large quantities can serve 
as a suitable and convenient antigen for large scale 
epidemiological pruposes (Arora et al. 1985). The existence 
of Leishmanial exoantigens was suggested by positive 
immunoperoxidase staining in the cytoplasm of Giant cells 
(infected with L. major) and non-parasitized, epithelial 
cells (Sells and Burton, 1981). 
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Soluble immune complexes containing anti-Leishmanial 
antibodies were demonstrated in human serum in visceral 
leishmaniasis (Casali and Lambert, 1979). It was also found 
that there are other substances released by L. donovani 
living promastigotes into the tissue, e.g. blood of infected 
hamsters. These substances differ from the excretory factors 
in their antigenic and biochemical characteristics. They 
were given the name of antigenically active glycoproteins 
(AAGP). The AAGP were found to consist of 6-7 antigenically 
distinct components. These components give reaction of 
identity and partial identity with human red cells and 
Mycobacterium butyricum. They also share certain antigens 
with a carbohydrate rich extract of T. cruzi (Decker-Jackson 
and Honigberg, 1978). 
8. Antigen Preparation 
Killed promastigotes were used by many workers as 
antigen (Holbrook et a1. 1981a; El-Amin et al., 1985). The 
promastigotes may be killed by formalin treatment or by 
freezing and thawing. For the formalin treatment, the 
promastigotes are harvested during log phase growth by 
centrifugation (900 x g for 30 minutes), washed three times 
in Earle's balanced salt solution (EBSS) and killed by 
suspension in 0.1X formalin for 30 minutes at room 
temperature. Formalin killed promastigotes (FKP) are kept at 
4°C overnight, washed three times, counted in a 
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haemocytometer and resuspended in EBSS at the desired 
concentration (Holbrook et a/., 1981a; Holbrook and Cook, 
1983; Cook and Holbrook, 1983). For preparing freeze-thawed 
antigen, the promastigotes are first suspended in EBSS and 
frozen at -70°C and then thawed at 37°C. This procedure is 
repeated three times. The criterion for the determination of 
promastigote death is the absence of parasite motility 
(Dwyer, 1976; Decker-Jackson and Honigberg, 1978; Cook and 
Holbrook, 1983). The other method of antigen preparation 
includes disintegration of promastigotes to get the cell-
free extract. For such preparation the promastigotes are 
obtained from 72 hour old cultures, washed twice by 
centrifugation and disintegrated in Mickle disintegrator for 
30 minutes. The obtained homogenate is further clarified by 
centrifugation (Ghatak et a1. 1982). The parasites may also 
be disrupted by sonication at 30 MHz for one minute burst for 
five times in a Branson (cell) disruptor. A complete 
disruption of cellular integrity may be verified by light 
microscopic examination (Rassam and Al-Mudhaffar, 1980; Cook 
and Holbrook, 1983). 
Soluble and particulate fractions are also separated by 
centrifugration of the sonicated promastigote preparation at 
4,000 X g for 20 minutes. The supernantent is passed through 
0.2 yUm millipore membrane filters. The particulate pellet is 
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washed three times with EBSS and suspended to the original 
volufTie (Ccok and Hoi brook, 1383). 
Rassam and Al-Mudhaffar (1980) prepared the soluble 
antigen by keeping the ultrasonicated promastigote suspension 
at 4°C for two hours and then centrifuging it at 7000 x g for 
one hour in a refrigerated centrifuge. The supernatant 
fraction representing the soluble antigen was dialysed for 20 
hours against distilled water at 4°C and then freeze-dried. 
The soluble and particulate fractions are also prepared 
by repeated centrifugation and washing of promasti gotes 
followed by osmolysis in sterile distilled water at room 
temperature. The lysed suspension is centrifuged at 12,000x g 
for 30 minutes in a refrigerated centrifuge (Jalees et a7., 
1981). Another method reported by Obaid et a7. (1985) 
utilizes the osmolysed parasite suspension which is further 
centrifuged at 105,000 x g for one hour to obtain soluble and 
particulate antigen fractions. The supernantant left after 
the last centrifugation represents the soluble antigen 
fraction (Ghatak et a7., 1982). 
9. HOST-PARASITE RELATIONSHIP 
The relationship between the parasite {Leishmania) and 
its different hosts is of special interest to the 
biologists. Intracellular symbiosis in leishmaniasis 
represents the ability of amastigotes to live in 
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macrophages. For establishing such intracellular symbiosis 
four sequential events are important: recognition, 
intracellular entry, survival, and multiplication (Moulder, 
1979). Leishmania macrophage interaction has been studied by 
infecting peritoneal macrophages in-vivo and in-vitro with L. 
donovani (Miller, and Twohy, 1967; Akiyama and Mcquillen, 
1972; Ebert etl a1. 1976; Chang and Dwyer, 1978). 
The binding of leishmania parasites to macrophages was 
studied in-vitro by light microscopy. It was found that a 
large number of promastigotes get themselves attached to the 
cells in a relatively short time (Chang 1981a). This binding 
was suggested to be mediated by discrete membrane molecules 
but not due to non-specific surface interaction (Chang 
1979). It was also found that binding of L. donovani 
promastigotes to hamster peritoneal macrophages is a legand 
receptor interaction involving antigenic surface membrane 
proteins. Thus the receptor mediated endocytosis appears to 
be the mechanism by which Leishmania gain entry into a 
macrophage (Chang 1981a). 
The entry of Leishmania parasites into macrophages 
depends on the phagocytic activity of these cells and the 
motility of the organisms. There is no specific orientation 
during this entry (Chang, 1979). A number of recent studies 
suggest that parasites reside within a vacuole of host cell 
20 
origin, and that lysosomes get to fuse with this 
parasitophorous vacuole soon after infection (Alexander and 
Vickerman, 1975; Chang and Dwyer, 1976; 1978). 
Chang and Fong (1983) have also reported similar 
findings from L. donovani infected hamster macrophages from 
an in-vitro system. Amastigotes are first lodged in 
phagosomes which are subsequently fused with the secondary 
lysosomes. The ability of Leishmania parasites to live on the 
secondary lysosomes of a macrophage may be due to certain 
intrinsic structures and dynamic properties of the parasite 
plasma membrane. Leishmania parasites undergo plasma 
membrane-rel ated changes on entry into macrophages at 
morphological, antigenic and molecular levels. Most of these 
changes probably reflect necessary steps for the transition 
of Leishmania parasite from an extracellular to an 
intracellular life. The mechanism by which these protozoans 
escape the macrophage killing and, infact, convert the 
infected macrophage into a cell supporting parasitic growth 
is not quite well known (Janovy, 1977). It was proposed that 
survival of Leishmanias in macrophages must be based on 
their resistance to enzymatic degradation into lysosome and 
to the microbicidal factors present in the intracellular 
micro environment (Chang, 1983). There are two possibilities 
for the resistance of Leishmanias to lysosomal enzyme 
degradation: 
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(i) Leishmania may have a naturally resistant surface to 
lysosomal, enzyme degradation (Chang and Dwyer, 1976). 
(ii) Leishmania may release factors which act as enzyme 
inhibitors (El-on et al. 1980), or change the intra-lysosomal 
pH (Coombs, 1982). 
It was found that promastigotes in the macrophages 
become shorter and lose their flagella. In most cases the 
intracellular environment and the body temperature of the 
mammalian host are both important for this differentiation 
(Lamy et. al., 1967; Forthingham and Lethimaki, 1969; Akiyma 
and Taylor, 1970). Lysosomal pH, and lysosomal constituents 
were seen to play a role in the induction of Leishmania 
cytodifferentiation (Chang, 1983). By electron microscopy, L. 
donovani amastigotes were found not only to survive but 
multiply within phagolysosomes of hamster macrophages, this 
appears to be crucial for establishment of intracellular 
symbiosis. 
Kutish and Janovy (1981) showed that the infective 
stage of L. donovani suppresses macrophage function beyond 
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the time at which initial lysosomal fusion with the 
parasitophorous vacoule occurs. Light and electron microscopy 
revealed that in the presence of lymphokines macrophages are 
activated and intracellular Leishmanias develop specific 
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subcellular lesions in the kinetoplast mitochondria (Chang 
and Chiao, 1981). 
Human polymorphonuclear cells (PMN) can ingest and kill 
L. donovani by the Hg Og - peroxidase halide system and may 
be capable of providing host defence against the invading 
promastigotes (Pearson and Steigbigel, 1981). The 
promastigotes were found to be susceptible to killing, in-
vitro, by Hg Og and other oxygen intermediates (Haidaris and 
Bonventre, 1982). 
10. LEISHMANIA INFECTIONS IN LABORATORY ANIMAL MODELS 
A considerable amount of information has been gained 
from experimental studies of immune responses in animal 
models of Leishmanial infections in the past few years. The 
choice of laboratory animal models for human leishmaniasis 
has generally been mice and hamsters. Monkeys are the recent 
additions to this menagerie (Wolf, 1976). It is evident that 
results from animal experimentation do not necessarily 
provide direct insight into specific human situations, as the 
precise relationship between infection of laboratory animals 
and the corresponding human diseases is always difficult to 
establish. Laboratory experiments usually bypass the natural 
route of infection and a given animal model will respond to 
inoculation of a particular parasite in different ways 
according to various factors such as age, dose and site of 
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inoculation, genetic background etc. In view of these 
shortcomings, however, it is also evident that in the 
absence of more appropriate means, animal experimentation 
remains the only rational approach to precisely understand 
the complex immunological reactions that may be elicited by 
the host as a result of leishmanial infection. The usefulness 
of any animal model of human leishmaniasis is clearly 
determined by the degree of similarity of such models to the 
human disease, particularly its immune responses and 
i mmunop rophy1 ax i s. 
Infections with L. donovani in mice do not mimic the 
fatal visceralizing diseases caused by this parasite in man. 
However, the broad spectrum of responses to this infection in 
mic provides an appropriate system for analyzing the innate 
and acquired resistance to nonlethal systemic infections 
(Blackwell, 1982). Since last few years hamsters have been 
proved to be a better animal model for L. donovani (Stauber, 
1963). Stauber (1963) reported 50 fold increase in parasite 
numbers in first week; enormous parasite load in liver and 
spleen, leading to death, following an intracardial 
inoculation of amastigotes in hamster. However, protection 
against reinfection is said to be present after cure 
(Heyneman, 1971). These models thus provide appropriate 
systems for analyzing protective capacities of antigenic 
preparations. They have specially helped us to define the 
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basic properties required for a vaccine against 
leishmaniasis, as also for the in vivo and in vitro tests of 
biological function needed to identify, define and assay such 
candidate vaccines. 
11. IMMUNOLOGICAL ADJUVANTS 
A basic difficulty in any attempt to survey adjuvants 
is that this deceptively simple term has various meanings. An 
adjuvant substance was defined by early research workers as 
one which stimulated the production of increased levels of 
antibody against protein antigens. This simplistic 
connotation was changed when it was demonstrated that in 
addition, adjuvants could stimulate cell mediated (delayed 
type hypersensitivity) or allergic responses against protein 
antigens and autoimmune reactions against homologous or 
heterologous tissue antigens. Latter, adjuvant substances 
have been shown to cause either an increase in the immune 
response (immunopotentiation), or conversely a decrease in 
the immune response (immunodepression). The later effect 
diminishes the physiologic value of the term adjuvant from 
the Latin adiuvare (to help) and more frequently, these 
substances are being referred to as immunomodulating agents. 
Accomodating all the above views and according to 
recent discussions (W.H.O. Tech. Rep. Series 595, 1976; 
Elderman R. 1980), the immunomodulating adjuvants can be 
defined as substances that are incorporated into or injected 
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simultaneously/ concomitantly with an antigen. Such 
substances help in potentiating non-specific immune 
responses. A safe immunomodulating agent, in addition to 
numerous other factors, must be able to control the harmful 
effects of an otherwise active substance. An immunomodulating 
agent should be able to increase the immunogenic potency of 
vaccines which are poorly immunogenic, or of relatively low 
molecular mass, or genetically manipulated antigens. An 
immunomodul at ing adjuvant must therefore conform to the 
following attributes: 
A) It should not induce hypersensitivity reactions to host's 
own tissues or to itself. 
B) It must not contain cross-reactive antigens with human 
tissues. 
C) It should not be carcinogenic, teratogenic or abortog«nic. 
D) It should not be contaminated with substances that might 
stimulate other immunological events not involved in the 
specific response. 
E) It must be biodegradable in human body. 
F) It must never produce harmful nodules or abscesses if 
administered intramuscularly (im) or subcutaneously. 
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G) It should not be unstable in the manufactured vaccine for 
at least a period of two years. 
The kind of immunostimulation produced by adjuvants 
should be measured and judged in relation to the sort of use 
for which they are intended. Also, acute and chronic toxicity 
assay of new candidate immunological adjuvants should be 
performed in controlled studies with attention to both the 
local and the systemic sites, following both single and 
multiple injections. 
For being clinically useful, vaccines containing 
adjuvants must have a specified shelf-life, for retaining 
useful adjuvant activity during the period and without 
developing properties that would increase adverse reactions. 
Unfortunately, these are indeed harsh conditions to impose on 
the adjuvant researchers, who must be cognizant with the 
biological activities of acceptable adjuvants. 
12. DIFFERENT TYPES OF ADJUVANTS 
An astonishing variety of substances has been shown to 
act as adjuvants, but those which have found a use in 
vaccines, or which have been major subjects of experimental 
investigation, have been elucidated and discussed here. 
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12.1. Aluminium Salts: 
Aluminium salts have been used particularly to raise 
the immunogenicity of toxoids in the development of antitoxic 
antisera. The first application of alum as an adjuvant was 
reported by Glenny et al . ( 1926) who used diphtheria toxiods 
precipitated with potassium alum KAl (804)2. ''2H2O, filtered 
and emulsified with water, in experimental vaccination of 
guinea pigs. The animals injected subcutaneously with the 
suspension of alum-toxoid precipitate developed immunity. 
Alum-precipitated vaccines were widely used for 
immunization of man and animals. As an alternative to alum 
precipitation, the toxoids are sometimes mixed with preformed 
gels of Al (0H)3) or AlPO^, to which they bind by ionic 
interaction to produce absorbed vaccines. Aluminium salts 
thus remain the sole adjuvants acceptable for human vaccines 
at the present time. 
12.2 Freund*6 Adjuvants 
Freund's adjuvants induce powerful eel 1-mediated 
responses, humoral immunity, break tolerance and potentiate 
tumour rejection. Their nomenclature honours the work of 
Jules Freund and his co-workers who established the 
conditions required to obtain reproducible activity, despite 
relying on materials of uncertain composition and of varying 
physical and chemical properties. 
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The history of these adjuvants is briefly outlined by 
Freund et al., (1945). Towards the beginning of this century, 
it was found that an antigen injected into a tuberculous 
'focus' gave heightened antibody titres and elicited a 
greater degree of delayed hypersensitivity in guinea pigs 
than when it was injected at other (non tuberculous) sites. 
Furthermore, they showed that heat-killed tubercle bacilli 
gave a marked tissue reaction, and antigens injected into 
this area of inflammation also elicited hypersensitivity. The 
same antigens when injected into acute inflammatory foci, 
produced with non-bacterial irritants including silica, 
tapioca or turpentine, however, did not elicit any greater 
immune response than upon injection into non-inflammatory 
tissues. This finding led Freund and Mc Dermott (1942) to 
develop adjuvants containing Mycobacteria. A key constituent 
of their adjuvant formulation was a lanolin like substance 
contained in Aquaphor, which is derived from wool fat and 
which contains added petroleum hydrocarbons. 
Further research has shown that adjuvant activity for 
induction of cell mediated immunity can be obtained also with 
variations from the classical (complete) Freund's adjuvant 
which consists of dead Mycobacterium suspended in mineral oil 
with an added emulsifier. Such variations can be achieved by 
(1) using either live or dead bacteria without an oily 
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mineral oil (with or without an emulsifying agent) is an 
adequate adjuvant to stimulate a humoral response to 
simultaneously applied immunogen, and when used for this 
purpose it is commonly described as Freund's incomplete 
adjuvant. 
Freund's incomplete adjuvant (i.e. oil emulsion 
adjuvant) is used in veterinary vaccines, but because of its 
tendency to cause sterile abscesses at the site of injection 
it has been abandoned for human use. 
Freund's complete adjuvant (killed mycobacteria 
suspended in the oil) is too inflammatory even for veterinary 
vaccines, but is most effective for raising high titre 
antibodies in experimental animals. 
12.3 Bacterial Lipopolysaccharides (Endotoxins) 
These are toxic principles, usually designated as 
Lipopolysaccharides (LPS), produced by gram-negative 
bacteria. They are bound firmly to the bacterial cell wall in 
a complex with protein, from which they are shed when the 
cell undergoes lysis. The term 'endotoxin' is therefore a 
misnomer because neither these substances originate from 
outside the cells, nor they are always toxic. However, they 
do show the property of increasing resistance to infection. 
Lipopolysaccharides (LPS) when administered by various routes 
in microgram amounts to laboratory animals have been shown
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elicit early IgM antibody responses (and later IgG responses 
in some species) against the polysaccharide components of the 
1i popolysacchari des. 
12.4 Bacillus Calmette-Guerin (BCG) 
B.C.G., a potent immunostimulant is presently the most 
commonly used non-specific stimulating substance in human 
therapy. As an immunostimulant BCG increases resistance in 
mice to several unrelated bacterial infections and markedly 
enhances the clearance of particulate materials by the 
reticuloendothelial system. Such stimulation persists for a 
very long period. The BCG enhances the production of 
antibodies and increases the number of spleen antibody 
producing cells. Also it increases delayed type 
hypersensitivity for particulate and soluble antigens, 
accelerates the rejection of skin allografts and transplanted 
tumours in mice and inhibits carcinogenesis. It also tends to 
modify the action of chemotherapeutic drugs such as 
cyclophosphamide (Mackaness, 1970). In respect to toxicity, 
the BCG may act synergistical 1 y or antagonistically with 
certain chemotherapeutic drugs. 
The BCG could help to promote the immunological 
rejection of tumours or augment resistance to infection in 
two ways. The immune rejection of tumour depends on the 
potentiating effect that mycobacteria exert on the immune 
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vehicle or, (2) by using an oily vehicle without a bacterial 
component. 
The first variant has been studied with a view to using 
adjuvant immunotherapy to treat cancer, with viable Bacillus 
Calmette-Guerin (BCG), a strain of Mycobacterium bovis 
(Mackaness et al. 1974) given in saline as the sole adjuvant 
material. 
The second variant seems to apply only to the 
immunization of rats, particularly in the context of 
sensitizing an animal to develop autointolerance to its own 
myelinated nervous tissue (allergic encephalomyelitis). For 
this purpose, the animals are usually challenged with a crude 
extract of spinal cord as the encephalitogen, a material 
which may contain natural emulsifiers with considerable 
lipids and other intrinsic pro-adjuvant components. As an 
extrinsic adjuvant it is only necessary to use an oily 
vehicle which need not be a mineral oil (White, 1973). This 
phenomenon clearly contradicts the generally accepted view 
that it is the bacterial component which provides the 
essential adjuvanticity for cell mediated immunity. 
This second variant has been evaluated at some length, 
for it has not always been appreciated that the vehicle may 
be of prime importance in determining the ultimate magnitude 
of an auto-allergic response. It has long been known that 
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response in general. The augmentation of resistance largely 
depends on inducing reticuloendothelial hyperplasia and 
hyperactivity. This is seen not only in animals injected with 
BCG but also when subjects with cell-mediated immunity are 
deliberately or inadvertently exposed to the specific 
antigen. The first effect of BCG also serves to enhance the 
host's capacity to make a specifically directed attack on the 
tumour cells or the parasite. The second attribute helps in 
the final expression of resistance by creating a more 
efficient scavenging system. The latter seems at present to 
be as crucial in promoting anti-tumour immunity as in 
augmenting resistance to some infectious diseases (Mackaness, 
1962). 
Stimulation of eel 1-mediated immunity is best achieved 
with a freshly prepared culture of BCG containing a high 
proportion of live bacilli. The mode of preparation and 
preservation on bacterial suspensions and the strains used 
are of importance for the efficiency of BCG adjuvanticity. 
There is evidence that optimum activity depends upon the use 
of bacteria from the pellicle growth rather than from 
submerged culture. Killed bacilli act mainly to increase 
circulating antibodies. 
In order to avoid any possible hazards arising from the 
use of strains of live, though attenuated bacilli in human 
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subjects, efforts have been made to substitute saprophytic 
bacteria or to use subcellular fractions of mycobacteria. 
12.5 Polynucleotides and Nucleic Acids 
Much of the earlier literature on this subject has been 
reviewed in a book (Beers & Braun, 1971). Originally, 
interest was aroused in these polyphosphates which contain 
the common purines and pyrimidines, since it was believed 
that endogenous oligonulceotides formed in some quantity -
after X-irradiation or treatment with cytostatic drugs or 
cell necrotic agents such as endotoxins - were responsible 
for the heightened (humoral) immune responsiveness observed 
in all these conditions. Concurrent discoveries further 
showed that these substances also induce immunity. 
The polynucleotides have been found to enhance antibody 
response to many antigens in a variety of mammalian and avian 
species. Their efficacy as adjuvants is illustrated by their 
capacity to render proteins in low concentrations of 10"^ ng 
antigenic. They are also found to be effective by multiple 
routes and need not be given together with antigens (Johnson, 
1976). Polynucleotides can affect host defence systems, non-
specifically, against a wide spectrum of infectious agents. 
Irrespective of the mechanisms, the potentiation of 
immunologic vaccines by polynucleotides offers promise for 
the future. 
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12.6 Glucan: 
Glucan, an extract from the inner cell wall of 
Saccharomyces cerevisae, has been variously claimed a non-
specific stimulant of the reticuloendothelial system. Beta 1, 
3 linked glucans have been demonstrated in a variety of 
laboratories to significantly enhance humoral and cellular 
immunity. Glucans have been uniformly demonstrated to 
materially modify the infectibi1ity of experimental animals 
to a wide variety of agents such as bacteria, fungus, virus 
and parasites. Additionally, glucans have been demonstrated 
to significantly alter growth and development of either 
syngenic, allogenic and autochthomous tumours in experimental 
animals, as also in a variety of human malignancies. They 
also have, through their ability to modify macrophage 
function, a profound influence on hemopoietic activity of 
bone marrow and spleen. In numerous studies conducted to 
date, glucans have also been demonstrated to effectively 
function as an adjuvant for tumour, viral, bacterial and 
parasitic vaccines. The broad spectrum of 
ummunopharmacological activity of glucans, coupled with the 
end metabolite being glucose, projects the continued 
development of these polyglucose immunomodulators for 
therapeutic purposes against a variety of infectious and 
neoplastic diseases, as well as their development as 
effective, non-toxic adjuvants. Glucan has been successfully 
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used in enhancing immune protection against L. donovani in 
hamsters (Obaid et. al., 1989; Hoi brook & Cook, 1983; Cook et 
al , 1982). Glucan has also been used for immunizations 
against P. berghei (Holbrook et al 1981, Kumar and Ahmad, 
1985) and Entamoeba histolytica (Ahmad et al, 1980, Sharma 
et. al., 1984). 
12.7 Muramyl Dipeptide (MDP) 
Freund's complete adjuvant developed in 1937 was found 
unsafe for use in human subjects due to the formation of 
focal granulomas (Stebly, 1963). A progressive series of 
biochemical studies attempting to purify the active adjuvant 
components gradually succeeded in isolating over smaller 
compounds. The smallest structure possible that still 
resulted in adjuvant activity was N-acetylmuramyl-L-alanyl-D-
isoglutamine or Muramyl Dipeptide (MDP). (Lederer, 1974; 
Kotani & Watanbe, 1975). Several investigators then examined 
the relationship between chemical structure and adjuvanticity 
(Chedid et al, 1976; Azuma et. al. 1976). Since that time MOP 
and MDP derivatives have been studied intensively and 
demonstrated to have numerous potent, diverse and interesting 
activities. While many of these may be clinically 
undesirable, they can often be dissociated from one another 
through the use of different derivatives (Tsujimoto et. al. 
1986). Muramyl dipeptide is able to replace killed 
mycobacteria in FCA for the induction of both humoral and 
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cellular immunity (Ellouz et. al . 1 974; .Merser et. al . , 
1975). It differs from FCA in that it does not induce a 
change in immunoglobulin levels in mice when given without an 
antigen (Leclerc, 1986). It is capable of inducing humoral 
immunity when given with an antigen in saline (Audibert et. 
al . , 1976) and induces an antibody response when given 
orally, even if the antigen is given by different routes 
(Chedid et. al., 1976). 
The classes of antibody elicited by an antigen given 
with MDP depend on the method of administration (Bomford, 
1988). Muramyl dipeptides have been shown to stimulate both 
specific and non-specific humoral immunity and cell mediated 
immunity, markedly measured by DTH to a wide variety of 
natural antigens from bacteria, viruses and protozoa 
(Audibert et al, 1976; Parant and Chedid, 1986). 
The precise mechanism of action of adjuvanticity is 
poorly understood and is clearly a multivariable. Muramyl 
dipeptide has a direct effect on lymphocytes. It is reported 
to enhance carrier-specific helper T-cell function (Leclerc, 
1986). Pharmokinetic studies have shown that aqueous MDP is 
cleared extremely rapidly from the bloodstream (Parant & 
Chedid, 1986). 
Protective immunity against malaria was produced in 
aotus monkeys using MDP and P. falciparum or P. Khowlesi 
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merozoites (Reese et al, 1978; Mitchell et. al., 1979). 
Khanna et al (1990) reported protection with MDP against P. 
Knowlesi infection in rhesus monkeys Khullar and Shegal 
(1990) have assessed the immuno protective role of MDP 
against P. berghei infection in mice. 
13. IMMUNITY IN VISCERAL LEISHMANIASIS 
Development of leishmaniasis is dependent on both host 
and parasite factors. The challenge is to separate 
invasiveness, pathogenicity and parasite survival into 
intrinsic host and parasite components (Heyneman, 1971) - in 
other words to determine the degree to which the clinical 
form of leishmaniasis is an expression of the parasite's 
genetic constitution (Virulence) or the host's innate 
susceptibility and capacity to respond (immunity). Although a 
comprehensive explanation of the immunobiology of the various 
forms of leishmaniasis is not possible, important advances 
have been made toward understanding the parasite's biology 
and defining critical aspects of their interaction with 
mammalian host defense mechanisms (Zuckermann, 1975). 
When a Leishmania-infected sandfly attempts to take a 
blood meal from its mammalian host, promastigotes are 
inoculated. Although Leishmania exist only transiently in the 
promastigote stage, the initial interaction of promastigotes 
with mammalian host defense mechanism is critical to the 
development of infection. Based on in vitro studies with 
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human serum and polymorphonuclear leukocytes, it appears that 
oromastigotes must escape potentially lethal humoral and 
cellular host defense mechanisms in order to gain entrance 
into macrophages. But once the Leishmanias have become 
amastigotes within macrophages, the resolution of infection 
depends pre-dominantly on cell-mediated immune mechanisms 
(Mauel & Behin, 1974; Rezai et al 1978). Inspite of the 
above studies, a role of humoral immunity against Leishmania 
infection cannot be ruled out; usually humoral responses 
accompany cellular responses in leishmaniasis as observed in 
laboratory animals. 
13.1 Cell Mediated Immunity 
Several animal models and in vitro systems have been 
used to investigate the role of cell mediated immunity in 
host defense against Leishmania (Zuckerman, 1975). Protection 
and immunity in leishmaniasis is generally conceded to be 
pre-dominantly cell-mediated (Garnham and Humprey, 1969; 
Zukerman, 1975). 
Lymphokines were shown to induce macrophage-mediated, 
killing of leishmaniasis in vitro (Behin and Louis 1984). 
Reed et al (1984) showed that mice infected with L. donovani, 
and treated with lymphokines-rich supernatants (encapsulated 
in liposoma) have significantly fewer liver parasites than 
the control group, demonstrating an in vivo activity of 
39 
lymphokines against an infections organism. The crude 
lymphokines which prime the human monocyte derived 
macrophages to generate H2O2, exerting a microbicidal 
activity against intracellular L. donovani, were found to be 
rich in interferon (JFN) gamma, were found to be rich in 
interferon (IFN) gamma. It was suggested that IFN gamma is 
the key macrophage activating molecule present within human 
lymphokines. It can enhance both the oxygen dependent and 
independent antiprotozoal mechanisms of human mononuclear 
phagocytes (Murray et al., 1983). In the active stages of 
leishmaniasis, cell-mediated immunity was found absent or not 
prominent. But after drug induced healing, generally, a 
vigorous delayed response appears and the individual becomes 
solidly immune (Hansen Bahr, 1961; Rezai et al , 1978). 
Impairment of cell-mediated immunity in Kala-azar appears to 
be of more generalized nature (Haldar et al , 1983). Some 
other workers have also shown that immuno supression in 
visceral leishmaniasis is both specific and non-specific 
(Carvalho et al , 1981; Ho et al, 1983). The results from 
these in vivo animal models of visceral leishmaniasis were 
similar to those from animal models of cutaneous 
leishmaniasis in demonstrating the primary role of cell-
mediated immune mechanisms in controling leishmanial 
infection. 
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The available in vitro data also indicates that the 
intracellular fate of amostigotes depends on the capacity of 
T-cells to activate macrophages (Zuckerman, 1975). 
Restoration of specific T-Cell responsiveness aided by 
antileishmanial drug therapy results in the reduction of 
antigenic load through parasite destruction alongwith 
decrease in circulating antibody levels, particularly that of 
immunoglobulin G class (Haider et al., 1983) Howard and Liew 
(1984) suggested that the faliure of immune control in 
inbred mouse models of visceralizing form of leishmaniasis 
involves generation of T-cells that suppress a potentially 
curative response. It was also found that affected human and 
rodent hosts commonly show abnormalities of T-cell function 
which may be related to change in macrophage physiology due 
to intracellular parasitism. Macrophages infected with L. 
donovani produce increased amounts of arachidonic acid 
metabolites with the potential for influencing cellular 
immune functions, and the inflammatory response to infection 
(Reiner and Malemud, 1985). 
It was further suggested that protection by specific 
eel 1-mediated immunity against L. donovani infection is not 
quite absolute. Such protection is probably dependent on 
other host related factors leading to the destruction of 
parasites and recovery of patient (Haldar et al., 1983). 
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13.2 Humoral Immunity 
Markedly elevated immunoglobulin level and antibodies 
to Leishmania are present in human visceral leishmaniasis 
(Haghighi et al, 1977; Gosh et. al., 1980). In general, the 
presence and magnitude of antibody responses in humans are 
inversely related to the extent and progression of disease. 
Farrell (1976) suggested that Leishmania parasites may be 
acted upon by humoral factors before phagocytosis actually 
occurs or that the entire infected macrophage is the target 
cell system. 
The role of highly raised concentrations of 
immunoglobulins in the evolution of visceral leishmaniasis is 
not known since most of the antibody produced is not specific 
for the parasite, and as such has no protective role (Neal 
et. al. 1969; Stauber, 1970). Preston et al. (1973) reported 
that the presence of plasma cells in resolving lesions is 
suggestive of antibody being associated with the healing 
process. 
It was recently observed in hamsters with L. donovani 
that there exists a relationship between the increase in the 
number of antibody secreting cells per spleen and the 
increase in. the number of parasites in this organ. These 
observations suggest that the hypergammaglobulinaemia present 
in infected hamsters may be the result of polyclonal 
activation of B-cells induced by components of this parasite 
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(Campos-Neto and Bunn-Moreno, 1982). It was also suggested 
that hypergammaglobulinaemia may be the consequence of an 
imbalance of regulatory T-cells, possibly associated with 
direct stimulation of hamster B-cells by L. donovani 
components (Bunn-Moreno et. al., 1985). 
Hoover et al . ( 1 985 ) showed that infection of 
individuals with L. donovani resulted in the production of a 
new, quantitatively and qualitatively distinct, immune 
mechanism directed against amastigote forms of the parasite. 
This immune mechanism was termed as 'antibody directed and 
alternate complement pathway - mediated' cytotoxicity. The 
resistance of L. donovani to serum complement factors may be 
the primary reason for its ability to escape from the site of 
inoculation and cause disseminated disease (Hoover et. al., 
1984). Pearson and Steigbigel (1980) showed that 
promastigotes are killed by activation of the classical 
pathway. In contrast, Chang (1981) reported that L. donovani 
promastigotes activate the alternate pathway. 
In vitro experiments showed that amastigotes enter 
macrophages without being opsonized by antibodies. Within the 
host macrophage amastigotes are protected from antibodies, as 
also from other circulating substances that might be harmful 
to the parasite (Report of WHO expert committe, 1984). 
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Chang (1981) suggested that humoral factors can alter 
the parasite - phagocyte interaction and that the presence 
and functional capacity of antibodies against Leishmania may 
vary during the course of infection. Their findings also 
demonstrate that serum from animals infected with Leishmania 
can actually inhibit the attachment of parasite to 
phagocytes. Antibody against Leishmania may inhibit the 
attachment of Leishmania to macrophages by masking important 
surface molecules and may thereby shift the mechanism of 
parasite attachment from a non-antibody-mediated, spontaneous 
parasite-phagocyte interaction to one mediated by FC 
receptors. 
14. PROTECTIVE IMMUNITY AND IMMUNOMODULATION STUDIES 
Protection of experimental animals against Leishmanial 
infection by using nonviable, or attenuated parasites as 
vaccines has not been fully achieved. On the contrary, such 
a treatment has frequently produced somewhat disappointing 
results (Lainson and Bray, 1964; Leema and Cole, 1974). Only 
a few experimental attempts have been made to analyze the 
antigens which are responsible for protective immunity 
(Preston & Dumonde, 1976; Mauel & Behin, 1982) and attempts 
to improve methods of immunization in man have been limited 
to improving vaccines comprised of vaible Leishmania major 
promastigotes (Greenblatt, 1980). These improvements have 
been concerned mainly with standardization, production, 
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storage and transport of the promastigote suspensions 
(Greenblatt, 1980). Loss of virulence is a special problem 
with the vaccines, whose efficacy depends upon the initiation 
of an ulcerative lesion (Koufman et al, 1978). However, the 
methods used to improve it are relevant to the development of 
any product intended for use in man. 
Immunogenic enhancement with appropriate 
immunomodulating agents, which specifically enhance the host 
defense mechanisms, may thus be required to elicit 
protective immunity. Although protection was conferred, in 
the absence of adjuvants, by I.V. injection of irradiated 
Leishmania (Horward et. al., 1982) and cloned avirulent 
promastigotes (Mitchell et al., 1984), but protection with 
semipurified antigens has required adjuvants (Bryceson et al, 
1970). However, the problems involved in finding a suitable 
adjuvant for generating cell-mediated immune responses, and 
the preparation being safe for human administration are still 
being worked upon by scientists in different laboratories. 
Two approaches have been adopted towards developing safe and 
effective immumoprophylactic measures for use against 
leishmaniasis. One is to attenuate, kill or disrupt the 
Leishmania so that they are no longer viable, but their 
antigens can still stimulate protective immunity. The other 
is to identify and isolate the protective antigens. 
45 
Immunization of hamsters with (70 K) amastigotes of L. 
donovani, intraperitoneally, protected recipients against 
lethal challenge (Corrodetti, 1977). About 60X of the 
recipients were protected completely; while the onset of the 
benign disease in the rest was delayed. However protection, 
was only manifest when animals were challenged some 60 to 
130 days after immunization; animals challenged 30 days after 
were not protected, but disease was retarded. This suggests 
that T-suppressor cell activity was stimulated by 
immunization with L. donovani, as for L. mexicana. An 
additional dose of promastigotes, 2 to 3 weeks after the 
first, did not improve the infection. 
Protection has also been conferred on both heunsters and 
mice against L. donovani by immunization with sonicated 
promastigotes, using glucan as an adjuvant (Holbrook et al, 
1981; Cook et al., 1982). Although glucan acts ae an 
immunopotentiator, apparently by nonspecific activation of 
macrophages (Cook et. al., 1982), best protection was 
obtained when it was administered with antigen. The I.V. 
route gave the best protection (Holbrook and Cook, 1983). 
Glucan has already proved useful as an adjuvant for a number 
of other vital vaccines and has already been evaluated 
clinically in man (Holbrook et. al., 1981). It, therefore, 
provides the most appropriate candidate for an adjuvant for 
use in man, although when administered intravenously may lead 
46 
to splenic and hepatic granulomas and enlargement of the 
organs, at least in hamsters (Holbrook and Cook, 1983). 
Glucan may be limited to use with L. donovani, as it did not 
enhance resistance when used alone or in conjunction with 
pentavalent antimony, in an attempt to cure infections with 
L. b. braziliensis in mice (Avila et. al . , 1982). 
Immunopotentiation when combined with chemotherapy proved 
effective in experimental visceral leishmaniasis in mice and 
significantly reduced the dosage of drug (Sodium antimony 
gluconate) required to clear L. donovani from the infected 
host cell (Haidaris & Bonventre, 1983). 
Stimulation with Bacillus calmette Querin (BCQ) 
vaccine has been reported to enhance resistance of mice and 
hamsters against Leishmania donovani infection and observed 
pathologic complications which appear to be exacerbated by 
BCG stimulation (Jarecki-Black et. al., 1984). Smrkoyski and 
Larson (1977) found that mice immunized with BCQ were 
protected against a subsequent challenge with L. donovani 
promastigotes. Such protection was abrogated, however, on 
treatment with cortisone (Smrkovski et. al., 1980). Smrkovski 
et. al (1980) reported that macrophages were nonspecifically 
activated by BCG to kill intracellular L. donovani, but 
because species of Leishmania and Mycobacterium may have 
antigenic similarities, a cross reacting antigen specific 
response could not be excluded. These findings with L. 
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donovani are in contrast to those of Grimaldi et al (1980), 
who found that neither BCG nor the immunostimu1 ant 
levamisole resulted in resolution of cutaneous 
leishmaniasis. 
Jarecki-Black et. al (1988), reported that mice on 
immunization with a sub-cutaneous protocol combining killed 
parasites and aluminium hydroxide gel exhibited significant 
resistance against subsequent challenge with L. donovani 
promastigotes. The effectiveness of aluminium hydroxide as 
an adjuvant appears to result, at least in part, from its 
ability to activate macrophages, thus aiding in the 
elimination of this intracellular parasite. White and 
McMahon (1990) demonstrated that low doses of purified 
protein (p 80) from L. donovani promastigotes when given with 
C. parvum as adjuvant could result an immune response in an 
experimental murine model of L. donovani infection. 
It has been recognized for a long time that the 
Leishmania comparises a complex mosaic of antigen which vary 
in their specificity. Mice have been successfully immunized 
against L. donovani with particulate fractions, administered 
either intravenously or subcutaneously in the presence of 
glucan, the response was assayed by a significant reduction 
in hepatic amstigote counts (Cook & Holbrook, 1983). Antigens 
alone afforded no protection. Some protection was also given 
by soluble fractions prepared by low speed centrifugation. 
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Obaid Qt. a"!. (1989) reported that immunization of 
hamsters with the microsomal fraction, in combination with 
glucan, confers considerable immune protection against L. 
donovani infection. 
15. Pathology of Visceral Leishmaniasis 
Kala-azar is defined as reticu1oendothe1iosis, 
resulting from the invasion of the reticuloendothelial system 
by L. donovani. Parsitized macrophages disseminate the 
infection to all parts of the body. In the spleen,liver and 
bone marrow particularly, the amastigotes multiply enormously 
in the fixed macrophages to produce a 'blockade' of the 
reticuloendothelial system. This leads to a marked prolife 
ration of the reticuloendothelial tissue in these organs. 
(Report of WHO Export Committee, 1990). 
The spleen is the most affected organ. It is grossly 
enlarged and the capsule is frequently thickened due to 
perisplenitis. It is soft and friable and cuts easily 
without resistance, due to absence of fibrosis. The cut 
section is red or chocolate in colour due to the dilated and 
engorged vascular spaces. The trabeculae are thin and 
atrophic. Microscopically, the reticulum cells are greatly 
increased in numbers and are loaded with LD bodies. 
Lymphocytic infiltration is scanty, but plasma cells are 
numerous. (Aikat et al., 1979; Chulay et al. 1985). 
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The liver is enlarged. The kuffer cells and vascular 
endothelial cells are heavily parasitised, but hepatocytes 
are not affected. Liver function is therefore not seriously 
affected, though p ro t h romti i n production is commonly 
decreased. The sinusoidol capillaries are dialated and 
engorged. Some degree of fatty degeneration is seen. The 
cut surface may show a nutmeg appearance (Pampiglione et. al. 
1974). Generally two types of lesions may be observed 
microscopically in the liver: a granulomatous reaction 
consisting of histiocytes and lymphogranulocytic cells with 
some eosinophils. The other type of lesions show extensive 
areas of haemorrhagic necrosis, representing disappearance of 
hepatocytes, erythrocytic congestion, extravasation and 
reticular collapse (Pampiglione et. al. 1974). 
The bone marrow is heavily infiltrated with parasitised 
macrophages which may crowd out haemopoietic tissues. 
Peripheral lymph nodes and lymphoid tissues of the 
nasopharynx and intestine are hypertrophic due to 
infiltration with parasitised cells, though this is not 
frequently seen in Indian cases. (Report of WHO Expert 
Committee, 1990). 
Anaemia occurs as a result of infiltration of the bone 
marrow as well as by the increased destruction of 
erythrocytes due to hypersplenism. Autoantibodies to red 
cells may contribute to haemolysis. Leucopenia ; with marked 
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cells may contribute to haemolysis. Leucopenia ; with marked 
neutropenia, and thrombocytopenia are frequently seen. 
Polyclonal hypergammaglobul inaemia is a common finding. 
(Aksoy et al, 1970; Bray & Wilson, 1972). 
Other changes include mucosal haemorrhage due to 
thrombocytopenia and prothrombin depletion, intestinal 
ulceration, myocardial damage, amylodosis and cloudy swelling 
of the liver (Pampiglione et. al., 1974). Leukopenia due to 
absolute reduction in all forms of granulocytes with moderate 
increase in lymphocytes and monocytes was found as usual 
feature of Kala-azar (Aikat et al . , 1979; Manson- Bahr, 
1971 ). 
Experimental leishmaniasis in golden hamsters results 
in splenomegaly and hepatomegaly. Maximum average 
enlargement of the liver is, however, comparatively of a 
lesser order than in the spleen. It is usually not as 
progressive, either. Anemia and leukopenia with marginal 
lymphocytosis,and having no increase in monocytes, are also 
some of the other features (Jalees et al, 1981). 
Hamsters inoculated intraperitoneal1y with L. donovani 
show progressive testicular atrophy. Spermatogenic cells of 
the semeniferous tubules show vacuolar degeneration with a 
decrease in the number of sperm cells, leading to a total 
azoospermia, Lymphoplasmacytic infiltrates with macrophages 
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containing leishmania parasites appear in the intertubular 
spaces. Testicular amyloidosis is thought to be a pathogenic 
mechanism related to a dysfunction of plasma cells. The 
stimulation of the RES is attributed to the antigenic 
character of parasties (Gonzalez et al., 1983). 
AIMS AND OBJECTS 
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AIMS AND OBJECTS 
The present study was aimed to investigate and develop 
an effective method of immunization against Lei shmani a 
donovani using male golden hamsters as the animal model. This 
investigation further aimed to carry out haemato1ogical, 
serological, immunological and histological studies in pre-
immunized, post-immunized and protected hamsters. Animals 
were immunized with different antigen fractions alone and in 
combination with MDP (Muramyl dipeptide) adjuvant for their 
ability to enhance resistance against L. donovani. 
The detailed plan of study was as follows: 
1. Promastigote stage of L. donovani (NICD: C-II Strain) was 
cultured on BHMARB medium for antigen isolation purposes. 
2. BHMARB medium was used only for in vitro maintenance of 
parasites. 
3. Golden hamsters were used for in vivo maintenance of 
parasites. 
4. The whole antigen was prepared by ultra sonication of 
promastigotes grown on BHMARB medium. 
5. The whole antigen was fractionated by using high speed 
centrifugation (105,000 x g for one hour) to separate 
soluble and particulate antigen fractions. 
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6. The whole antigen and the other antigen fractions were 
characterized by estimating their protein, carbohydrate 
and DNA contents. Molecular weight of various isolates 
were estimated using SDS-PAGE. 
7. The antigenicity of the whole antigen and its various 
fractions was checked by means of IHA and agar diffusion 
techniques against positive kala-azar patient sera. 
8. Golden hamsters were immunized in different experimental 
groups. Animals were immunized with whole, soluble and 
particulate antigen fractions alone and in combination 
with MDP (Muramyl dipeptide) adjuvant. 
9. Assessment of humoral immune responses was carried out by 
means of various antigen-antibody reactions such as IHA 
and ELISA. 
10. Gel 1-mediated immunity was demonstrated by the appearance 
of delayed type skin hypersensitivity reaction, in vivo. 
Macrophage migration inhibition tests were also used for 
in vitro detection of CMI. 
11. In an effort to monitor the course of the disease, or the 
appearance of immunity, haematological studies were also 
carried out in experimental, animals. 
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12. Following immunization the test animals were challenged, 
in order to carry out the protection studies in 
experimentally immunized animals, and non-immunized 
controls. 
13. The intensity and the extent of issue damage by 
leishmania parasites was determined by establishing the 
number of parasites in the liver and spleen. 
Histopathological changes in the infected organs were 
simultaneously studied. 
14. The humoral and ce11-mediated immune responses as 
generated in the immunized animals were assayed by 
employing several, in vitro and in vivo test procedures. 
MATERIALS 
MATERIALS ^ ^^ 
1. Laboratory Culture 
Leishmania donovani parasites (NICD : C-II strain) were 
cultured on brain heart infusion agar with rabbit blood 
medium (BHMARB). The above strain was initially obtained 
from the Biochemistry Division of the National Institute of 
Communicable Diseases (NICD), Delhi, India. 
2. Media and Buffer 
Dehydrated Brain Heart Infusion powder and Bacto Agar 
from Difco Laboratories, Detroit, Michigan, USA were used for 
culturing the parasites. The Nutrient Broth, Sabouraud's 
Dextrose Agar and Cooked Meat Medium were prepared according 
to the manufacturers instructions and sterilized in the 
laboratory. Hanks balanced salt solution (HBSS) and 0.1 M 
phosphate buffer saline (PBS) pH 7.2 were prepared in the 
laboratory according to the prescribed procedure. 
3. Animals 
Healthy male golden hamsters (CDRI strain), each 
weighing around 80-100 gms, were purchased from the Animal 
House Facility of the Central Drug Research Institute (CDRI), 
Lucknow, India. Hamsters were routinely used for in vivo 
maintenance of Leishmania parasites and for immunization 
purposes. 
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4. Chemicals 
Analytical grade potassium phosphate (monobasic), 
potassium phosphate (dibasic), sodium carbonate, sodium 
chloride, copper sulphate, sodium potassium tartarate, sodium 
hydroxide, sodium hydrogen phosphate, disodium hydrogen 
phosphate, phosphoric acid, lithium sulphate, sodium 
tungstate, sodium molybdate, glucose, magnesium chloride, 
sulphuric acid and formaldehyde were purchased from B.D.H. 
(India). Tannic acid was purchased from W.J. Bush and Co., 
England, while Leishman stain was purcahsed from B.D.H., 
England. Methanol was obtained from Merck and Company, Ltd. 
and bovine serum albumin from SIGMA chemical company. Acetic 
acid (glacial) was purchased from B.D.H. (India). Tween 80 
was obtained from Riedel, Germany. Heparin was purchased from 
Leo, Copenhagen, Denmark. 
The chemicals used in sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) were obtained as 
follows: 
Acrylamide, N,N'-Methylene bisacry1 amide (BIS), 2-
Mercaptoethanol (LOBA-Chemie Co. Bombay - India). Bromophenol 
blue, SDS-Lauryl sulfate. Ammonium persulphate, N,N,N,N-
tetramethylethylene diamine (TEMED) from B.D.H., England. 
Urea from Merk Germany. Brilliant blue (Commassie brilliant 
blue) from SIGMA, U.S.A. 
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5. Anticoagulants 
Acid citrate dextrose (ACD), Sodium citrate, 3.8 
percent and Ethylene diamine tetraacetic acid (EDTA) were 
purchased from B.D.H. England. 
6. Preservatives and Antibiotics 
Sodium azide was obtained from Riedel, Germany. 
Penicillin, Streptomycin and Gentamycin were locally 
purchased. 
7. Immunoadjuvants 
MDP was supplied as a gift through the courtesy of 
Dr.Francier and Late Prof.E.Lederer from Choay Chimie 
Reactifs, Paris, France. 
8. Conjugates and Substrates 
Anti-hamster IgG was prepared in the laboratory. 
Alkaline phosphatase and p-nitropheny1 phosphate wore 
purchased from SIGMA, U.S.A. 
9. Capillaries and Dialysis Tubing 
Dialysis tubing and capillaries were purchased from 
Arthur H. Thomas Company, U.S.A. 
10. Anaesthesia 
Anaesthetic ether I.P. was obtained from Alembic 
Chemical Works Company, Baroda, India. 
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11. Human Antisera 
Anti-L. donov sni huiTian sera wer e made avai lable through 
the courtesy of Dr. S.G. Tewari, Professor of Medicine, J.N. 
Medical College, A.M.U., Aligarh. 
All glassware was sterilized before use and double 
glass distilled water was routinely used to make solutions. 
METHODS 
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1 . In Vitro Cultivation of Parasites 
The promastigotes of L. donovani (NICD: C-II strain) 
were maintained on brain heart infusion agar with rabbit 
blood (BHMARB) medium according to the method of Jalees et. 
al. (1982). 
1.1 Preparation of BHMARB Medium 
Collection of Rabbit Blood: 
Two millilitre of 3.8* sodium citrate solution was 
first dispensed in each thoroughly cleaned vial. The capped 
vials were then autoclaved at 121°C for 15 minutes. One 
rabbit was anaesthesized by ether and the local area dressed 
with spirit and iodine. Using aseptic techniques, about 8 ml 
rabbit blood drawn by direct cardiac puncture was delivered 
into each vial containing anticoagulant, and gently mixed to 
prevent clotting. For inactivation the vials were kept at 
56°C in a water bath for 30 minutes. 
Preparation of Solid Phase: 
Composition: 
Brain Heart Infusion Powder (Difco) 3.7 gm 
Bacto - Agar (Difco) 2.0 gm 
Double distilled water 100 ml 
Citrated rabbit blood 15 ml 
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Brain heart infusion power and Bacto agar were 
dissolved in water in a 250 ml flask, which was constantly 
stirred and kept in a hot water bath until the contents 
appeared transparent. The flask was then autoclaved at 151b 
pressure for 15 minutes and allowed to cool to 37°C. 
Samples of citrated rabbit blood were aseptically added 
to the above flasks containing medium, while the contents 
were mixed. For the preparation of maintenence medium slants, 
3 ml samples of prepared medium were transferred to each 
sterile tube which was left for solidification in a slanting 
position for 15 minutes. Each tube was then corked properly 
and kept in the refrigerator. 
1.2 Preparation of Hank's Balanced Salt Solution (HBSS) 
Stock-A 
Composition 
(1) Sodium chloride 16 gm 
Potassium Chloride 8 gm 
Magnesium sulphate 0.2 gm 
Double distilled water 80 ml 
(2) Calcium Chloride 0.28 gm 
D.D.W. 10 ml 
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Solutions 1 and 2 were mixed slowly by constant shaking 
and the volume made upto 100 ml by adding double distilled 
water 
Stock-B 
Disodium hydrogen phosphate 0.75 gm 
Potassium dihyrogen phosphate 0.12 gm 
Double distilled water 80 ml 
The final volume was made upto 100 ml by adding D.D.W. 
Sodium Bicarbonate (1.4X) 
Sodium bicarbonate 0.14 gm 
D.D.W. 10 ml 
Glucose Solution (5X) 
Dextrose 0.5 gm 
D.D.W. 10 ml 
Final Solution 
Aliqots of 5 ml solution from Stock-A and Stock-B 
were dispensed in sterile flasks and mixed thoroughly. About 
5 ml solution of 5X Destrose was added to each flask and 
mixed. Each flask also received a 2.5 ml solution of 1.4% 
sodium bi-carbonate, which was then adjusted to 100 ml volume 
by the addition of D.D.W. The above solution was sterilized 
by passing it through a seitz filter. 
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Final Preparation of Medium 
For in vitro maintenance of parasites, 3 ml of H3SS was 
aseptically added to each tube containing 3 ml of basic 
medium (BHMARB). The tubes were stored for their subsequent 
use. 
1.3 In vitro Maintenance of Parasites 
Each tube containing basic medium (BHMARB) and HBSS (3 
ml each) received an 0.1 ml overlay containing 1-2 x 10^ 
promastigotes/ ml. The incoulated tubes were kept in a BOD 
incubator at 25°C ± 2°C. At weekly intervals, fresh tubes 
were routinely inoculated in the manner described above. 
During inoculation, a small sample from each tube was 
routinely stained with Leishman and examined under the 
microscope for checking any possible contamination. 
1.4 Sterility Checking 
A clean grease-free slide was used for making a smear 
of culture overlay. The smear was air dried and fixed in 
methanol for 4 minutes before being stained. 
The staining solution was prepared by mixing equal 
volumes of Leishman stain and phosphate buffer saline (0.01 
M, pH 7.2). Slide smears were stained by pouring the dye over 
the slides which were left for 30 minutes and later washed 
with water. The stained smears were then air dried and 
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examined under an oil immersion objective for detecting any 
contaminant 1 ike bacteria and fungus, etc. 
1.5 Preparation of Leishman Stain 
Leishman stain was prepared by mixing 150 mg of 
Leishman stain powder with 100 ml of acetone free methyl 
alcohol (98%). The above solution was kept in a clean dry 
contai ner. 
1.6 Rate of Multiplication and Parasite Counts 
According to the method of Jalees et. al. ( 1982) the 
rate of parasite multiplication was calculated by dividing 
the promastigote count per ml (on day of the examination) 
with the initial count, or with the previous day's count. The 
formula used for these calculations was as follows: 
No. of promastigotes inoculated 
Counts per ml 0 day = 
Volume of overlay/media + Volume of 
Inoculum 
Count after 6 days 
Time of multip!ication= 
Count on 0 day 
A 10 fold dilution oof the culture overlay or the 
infected homogenate was made in normal saline, while the 
motile nucleated Leishmania promastigotes were counted in a 
Neubauer Haemacytometer counting chamber. 
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2. In Vivo Maintenance of Parasites 
Three hamsters were inoculated intraperitoneally with 
about 1 X 10® promastigotes of NICD-C II strain of L. 
donovani grown in BHMARB medium. After seven weeks, one 
hamster was killed by ether. The spleen was excised in 
sterile conditions and homogenized in 10 ml Tris (0.2 M) -
sucrose (0.25 M) buffer, pH 7.8, using a Ten Broeck glass 
homogenizer. The homogenate was centrifuged at 150 x g for 10 
minutes and the pellet was discarded. The supernatant was 
centrifuged at 1000 x g for 20 minutes and the resultant 
supernatant (first wash) discarded. The pellet was 
resuspended in 10 ml Tris -sucrose buffer. The above 
procedure was repeated twice (Brun et. al . , 1 976 ). After 
resuspending the washed amastigotes in a small amount of 
Tris-sucrose buffer, one milliliter of this homogenate was 
inoculated into BHMARB medium. Several impression smears 
were air dried, fixed with methanol and stained with Leishman 
stain. 
3. Antigen Isolation 
The overlay from 6 day old cultures was diluted in 
equal amounts of sterile normal saline. The diluted overlay 
from a culture tube containing 40 xig gentamycin/ml was 
centrifuged at 2000-2500 rpm for 30 minutes at 4°C. The 
deposit from the first wash was suspended with half the 
original volume of normal saline and centrifuged again at the 
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same speed. The second wash deposit was resuspended with 
1/4th the volume of normal saline and recentrifuged. Washing 
was repeated 5-6 times till the supernatant became absolutely 
clear. The deposit was then resuspended in double distilled 
water to give a concentration of 1/13th - 1/14th of the 
original volume. The parasite was dispensed by subjecting the 
above suspension to shaking in orbital shaker (Metrix 
Scientific Instruments) and left overnight in the 
refrigerator. Next morning, a smear of the antigen 
preparation was again checked under the microscope to ensure 
that all the parasites were osmolysed (Jalees et. al., 1981; 
Obaid et. al. , 1985). The osmolysed parasites were used as 
whole antigen preparation for various experiments in this 
study. 
4. Fractionation of Whole Antigen 
Fractionation of whole antigen samples was caried out 
according to the method described by Ghatak et. al. (1982) 
with slight modifications- A portion of whole antigen was 
centrifuged at 105, 000 x g (Sorvall Ultra centrifuge, OTD 
50B) for one hour at 4°C. The deposit obtained after such 
centrifugation was employed as particulate antigen fraction, 
while the supernatant was used as soluble antigen fraction. 
The various antigen preparations such as whole and 
particulate antigen were further disrupted by ultrasonication 
in a 50 Watt, 9 KHz magnetostrication oscillator (Braun, 
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U.S.A.) for 18 minutes. The protein contents of the whole, 
soluble and particulate antigen samples were adjusted to a 
concentration of 1 mg/ml. Appropriate aliqots were then 
stored at -70°C until used. 
5. Biochemical Characterization of Antigen 
5.1 Protein Estimation 
Protein was estimated by Lowry's method (Lowry et. al., 
1951) using bovine serum albumin as the standard. 
(a) Preparation of Folin Phenol Reagent 
Folin phenol reagent was prepared according to the 
method of Folin and Ciocalteu (1927). The reagents 
contained: 
100 gm of Sodium tungustate 
25 gm of Sodium molybdate 
50 ml of Phosphoric acid (85X) 
100 ml of concentrated Hydrochloric acid. 
A 1.5 litre capacity round bottom flask wsis used to 
dissolve the above constituents in 700 ml of distilled water. 
The contents of the flask were refluxed for 10 hours 
continuously by using a refluxed condensor. Subsequently, 150 
gm of lithium sulphate, 50 ml of water and a few drops of 
liquid boiled for 15 minutes to remove excess bromine. The 
mixture was allowed to cool. Finally, the total volume was 
brought to one litre by the addition of distilled water. The 
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above solution was filtered and stored until used in a dark 
brown bottle kept in a cupboard. 
(b) Preparation of Copper Reagent 
Copper reagent was prepared by mixing the following 
reagents: 
Four percent (W/V) sodium carbonate in double distilled 
water, 4 percent (W/V) potassium sodium tartrate and 2 
percent (W/V) copper sulphate in the ratio of 100: 1: 1 
(V/V/V) were mixed together. 
About 0.1 ml of antigen or bovine serum albumin was 
brought to 1 ml by the addition of distilled water. A 5 ml 
sample of freshly prepared copper reagent was added to it and 
incubated for 10 minutes at room tempertaure. After 
incubation, 1 ml of 1:4 (V/V) diluted Folin's reagent was 
added to each tube. The tubes were shaken and left 
undisturbed for 30 minutes. The colour intensity of the 
reaction was read at a wave length of 700 nm by using a 
Bausch and Lomb Spectronic-21 spectrophotometer. 
5.2 Carbohydrate Estimation 
Amount of carbohydrates associated with L. donovani 
antigen was estimated by using the method of Dubois et. al. 
(1956). Glucose solution was used as the standard. 
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(a) Preparation of Standard Solution: 
10 mg of glucose was dissolved in 100 ml of double 
distilled water. 
(b) Preparation of Phenol Reagent: 
Phenol reagent was prepared by dissolving 8 gm of 
phenol in 100 ml of double distilled water. 
An 0.1 ml of antigen or glucose solution was brought 
upto 2 ml volume by the addition of double distilled water. 
Then 1 ml of freshly prepared phenol reagent was added. 
Later, 5 ml of concentrated sulphuric acid (95.5X) was added 
to the above mixture. The tubes were shaken vigorously and 
cooled at room temperature. The colour intensity was read at 
a wave length of 490 nm. 
5.3 DNA Estimation 
Estimation of DNA was carried out according to 
Burton's method (Burton, 1956). 
(a) Diphenylamine Reagent: 
This was prepared by the addition of 750 mg of 
diphenylamine to 50 ml of glacial acetic acid containing 0.75 
ml concentrated H2 SO^. 
After mixing 1 ml of antigen to 1 ml IN perchloric 
acid, the mixture was kept at 70®C in a water bath for 15 
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minutes. Then 0.1 ml of 5.43 mM acetaldehyde was added, after 
the addition of 2 ml of diphenyl amine reagent. The tubes were 
left at room temperature for 16 hours. The colour intensity 
was recorded at 600 nm. 
5.1 Measurement of pH 
A pH meter (Elico L-j--j20^ w®® used for all pH 
measurements. Sodium tetraborate (0.1 M, pH 9.18) and 
potassium hydrogen phosphate (0.005M, pH 4.0) were used as 
standard buffer solutions to calibrate the pH meter. 
5.5 Spectrophotometric Measurements 
Spectrophometric measurements in the ultraviolent and 
visible range were carried out an a Bausch and Lomb 
Spectronic-21 Spectrophotometer. All these measurements were 
carried out at room temperature. 
5.6 Molecular Weight Determination by SDS - PAGE 
Sodium dodecyl sulphate po1yacry1 amide gel 
electrophoresis (SDS-PAGE) was used for the separation of 
protein subunits of Leishmania donovani promastigote antigen 
fractions, and for determination of the molecular weights 
according to the method of Laemmli (1970) with slight 
modifications. The marker proteins used in this test were in 
the Mp of : 29,000, 45,000, 66,000, 97,400, 116,000, 205,000 
dalton as carbonic anhydrase, egg albumin, bovine albumin 
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plasma, phosphory1ase B, p-galactosidase and myosin 
respectively. 
(A) Preparation of Reagents: 
The stock solutions were prepared and stored at 4°C in 
brown glass bottles. 
(1) Stocking Gel Buffer or upper Gel Buffer: 0.5 M tris -
(hydroxymethyl) - aminomethane and 0.4% SDS - Lauryl sulphate 
were dissolved in 1 litre distilled water. The pH of this 
solution was adjusted at 6.8 with 1 N HCl. 
(2) Separating Gel Buffer or Lower Gel Buffer: 1.5 M tris 
(hydroxymethyl) - aminomethane and 0.4X SDS - Lauryl sulphate 
was dissolved in 1 litre distilled water. The pH of this 
solution was adjusted at 8.8. 
(3) Electrophoresis Buffer: A solution containing 0.05 M tris 
- (hydroxymethyl) - aminomethane, 0.384 M glycine, 0.1* SDS 
- Lauryl Sulphate was prepared in 1 litre distilled water 
at a pH of 8.3. 
(4) Sample Buffer: 
EDTA 0.001 M 
SDS-Lauryl Sulphate IX 
B-Mercaptoethanol 5X 
Glycerol 40% 
Bromophenol Blue 0.002% 
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The above constituents were dissolved and diluted to 
100 ml with distilled water. 
(5) Acrylamide Stock Solution: Samples of 30% Acrylamide and 
0.8% N, N Methylene biacrylamide were dissolved and diluted 
in 100 ml distilled water. 
(6) Fixative solution: This was prepared by combining the 
following: 
Isopropanol 25 ml 
Glacial Acetic Acid 10 ml 
Distilled Water 65 ml 
(7) Staining Buffer: This was prepared by mixing the 
following: 
Coomassie Blue (R-250) 0.2 gm 
Methanol 25 ml 
Acetic Acid 10 ml 
Distilled water 65 ml 
(8) Destainer: The destainer used in this study contained: 
Methanol 25 ml 
Acetic Acid 10 ml 
Distilled Water 65 ml 
(9) Ammonium Persulphate Solution: A 10% ammonium persulphate 
solution was freshly prepared in distilled water. 
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(10) Composition of separating Gel: The gel was prepared by 
combining the following: 
Acrylamide solution 9.6 ml 
Separating gel buffer 10 ml 
Distilled Water 19.66 ml 
N,N,N',N'-tetramethyl-ethylene diamine 0.04 ml 
Ammonium per sulphate solution 0.40 ml 
(11) Composition of stocking Gel: The gel was prepared by 
combining the following: 
Acrylamide solution 2.66 ml 
Stacking gel buffer 5.0 ml 
Distilled water 12.0 ml 
N,N, N',N'-tetramethyl ethylene diamine 0.02 ml 
Ammonium persulphate solution 0.20 ml 
(12) Preparation of sample: The antigen samples were adjusted 
at a concentration of about 1 mg protein per ml in the sample 
buffer. 
(B) Procedure 
Thoroughly clean and dimethyldichlorosilane, treated 
glass tubes were placed in racks in an exactly vertical 
position. The components of the separating gel were 
thoroughly mixed. The gel solution was immediately dispensed 
in tubes, and overlayed with water. The tubes were left 
undisturbed for about 40-60 min. and then the water layer 
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was removed. After this, the stacking gel mixture was filled 
in the tube and the water layered immediately. The tubes were 
left to gelatinize for about 60-90 min. The marker proteins 
as well as the sample solutions were dissolved in sample 
buffer and incubated at 37°C for 2 hrs. A 10 >ul sample was 
loaded into each gel tube. The electrophoresis was carried 
out at a constant current of 5 mA/ gel tube at 100 volts for 
about 10 hours. The constant current was passed until the 
marker dye (bromophenol blue) was 1 cm from the anodic end 
of the gel. The gels were removed from the tubes by 
squirting water from a syringe between the gel and the glass 
wal 1. 
(C) Staining and Destainlng 
The center of the bromophenol blue dye front was marked 
with a piece of fine wire. The gels immersed in fixative 
solution for about 60 minutes. The staining was carried out 
by keeping the gel rods for 30 min in the staining solution. 
The gel rods were destained by diffusion against several 
changes of the destainer. 
The migration distance of the tracking dye and of the 
blue protein zones from the top of the gel was recorded. 
Final gels were stored in the destaining solution. 
The relative mobility (Rf) of a protein was determined 
by dividing its migration distance from the top of the gel to 
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the center of the protein band by the migration distance of 
the bromophenol blue tracking dye from the top of the gel. 
Distance of protein migration 
Distance of tracking dye migration 
The values (as abscissa) were plotted against the 
known molecular weights (ordinate on a semi-1ogrithmic 
graph). The molecular weights of unknown proteins were 
estimated with the help of a calibration curve. 
6. Checking the Antigenicity of Parasite Antigens 
The antigenicity of whole antigen was further checked 
against clinically positive humain serum samples obtained 
from Kala-azar patients by employing indirect 
haemagglutination (IHA) tests. The antigenicity of solution 
and particulate antigen fractions was checked by agar 
diffusion technique against the abovQ serum samples. 
All the sera samples were first checked for the 
presence of specific antibodies against a reference, 
standard antigen sample in Indirect Fluorescent Antibody 
(IFA) tests. 
6.1 Indirect Fluorescent Antibody (IFA) Test 
(a) Preparation of Antigen Indirect fluorescent antibody, 
test was caried out according to the method of (Abdalla, 
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1977). The promastigotes used for IFA test were harvested by 
centifugation of overlay taken from 6 day old cultures at 750 
X g for 10 minutes. The supernatant was discarded and the 
deposited pellet was washed with PBS, pH 7.0-7.2, five to 
six times till the supernantant became clear. The pellet was 
resuspended with PBS, then a drop (3-5 ml) was spotted on a 
clean slide. The slides were air dried, fixed in acetone for 
15 minutes and again air dried. The acetone fixed slides were 
wrapped in tissue papers and packed in air tight containers 
in small batches and stored at 4°C. 
(B) Staining Procedure 
Fluorescein isothiocyanate conjugated with anti-human 
IgG (r-chain specific) was used in the test. The test sera 
were inactivated at 56°C for 30 minutes. Two-fold serial 
dilutions were prepared with PBS. 
Antigen coated slides were removed from freezer and air 
dried. The antigen spots were covered with drops of 
successive serum dilution and incubated in a humid chamber 
at 37°C for 30 minutes. After incubation, slides were rinsed 
off with PBS in two or three changes of PBS for 10 minutes 
each. The smears were blotted dry and optimum dilution of 
conjugate was applied to the antigen spots. The slides were 
then mounted with covers!ips using buffered glycerol (90^). 
The edges of coverlips were sealed with finger nail varnish. 
Two control slides were prepared by placing a drop of PBS 
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buffer on one slide and the positive Kala-azar antiserum on 
the other. The slides were stained as above. The stained 
slides were examined immediately using a fluorescent 
microscope equipped with appropriate filters (Olympus, 
Japan). 
6.2 Indirect Haemagglutination Test (IHA) 
Indirect haemagglutination test was done according to 
the method of Mathews et. al . , ( 1 975 ) for checking the 
antigenicity of Leishmania whole antigen. 'U' bottomed 
microtitre plates were used for this test. Sheep red blood 
cells (SRBC) were washed four times in isotonic phosphate 
buffer saline (PBS), pH 7.2, by centrifugation for 10 minutes 
at 1500 rpm. A 3% suspension of SRBC was prepared in 
isotonic PBS. The diluted RBC suspension was mixed with an 
equal volume of 1/20, 000 tannic acid and incubated at 4° C 
for 30 minutes with intermittent shaking after incubation, 
the suspension was centrifuged at 1200 rpm for 10 minutes 
and tanned SRBCs were washed three times with PBS containing 
0.5X bovine serum albumin (BSA). The above was resuspended 
in PBS containing BSA to obtain a final concentration of 3* 
(V/V). The tanned SRBCs were sensitized with an equal volume 
of diluted antigen and incubated at 37° C for 30 minutes 
with intermittant shaking , so that the RBCs were uniformly 
coated with antigen. After incubation, they were centrifuged 
to remove the uncoated antigen supernatant. The pellet was 
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washed 3-4 times with PBS containng BSA. A 1.5% (V/V) antigen 
coated RBC suspension was finally made for using it in the 
tests. The antisera samples were serially double diluted 
from 1:2 to 1:32768. Each well in the plate received 25 ul of 
Kala-azar serum alongwith an equal volume (25 ul) of tanned 
and antigen sensitized RBCs. The plates were rotated gently 
for five minutes, covered and sealed in a humid chamber and 
incubated at room temperature for 2 hours. The plates were 
kept overnight at 4° C. The formation of mat-like or carpet 
like patterns indicated a positive reaction. The highest 
dilution of the serum giving a positive reaction was 
recorded. 
6.3 Agar Diffusion Technique 
Agar diffusion technique was used for testing the 
antigenicity of whole antigen along with , soluble fraction, 
and particulate fractions. The test was performed according 
to the method described by Ouchterlony (1949). Clean slides 
were first coated with 0.2% agar and drying them at room 
temperature. One percent W/V agarose (Sigma) in PBS 
containing 0.2% sodium azide was then poured on the slides. 
The slides was allowed to solidify. The wells of 2 mm 
diameter at a distance of 5 mm apart were later cut in agar. 
The central well was filled with reacting antisera, while 
the peripheral wells were filled with antigen samples. The 
glass slides were kept overnight in a
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temperature and subsequently stored at 4° for 72 hours. The 
slides were then stained with 0.5% comassie brilliant blue 
after drying. 
7. Immunization Studies 
All immunization experiments were carried out in 
healthy, male golden hamsters weighing between 80—100 gms. 
These studies were done in two separate experiments. In the 
first experiment, the animals in different batches were 
accordingly inoculated with samples of whole antigen, soluble 
antigen fraction and particulate antigen fraction. In the 
second set of experiments, the animals were similarly 
inoculated with different antigen preparations such as whole 
antigen, soluble antigen fraction and particulate antigen 
fraction in combination with Muramyl dipetide (MDP) as an 
adjuvant. The immunization schedule was as follows: 
7.1 Experiment No.1 
Group I : Animals immunized with whole antigen 
Group II : Animals immunized with soluble antigen fraction. 
Group III : Animals immunized with particulate antigen 
fraction 
Group IV : Animals inoculated with normal saline only. 
Each hamster was intraperitoneally inoculated with four 
injections, each containing 0.2 mg antigen protein given at 4 
day intervals. The inoculum in each injection was made up to 
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0.5 ml with the addition of saline. The number of hamsters in 
each group was 25. The immunization schedule is shown in 
Table 1 . 
Eight animals randomly selected from each group were 
bled in the 2nd, 4th and 6th week after the last immunizing 
injection. The sera obtained from these blood samples was 
used for the detection of sequentially appearing anti-
Leishmanial antibodies. 
7.2 Experiment No.2 
Group I: Animals immunized with whole antigen + MDP 
Group II: Animals immunized w^th soluble antigen fraction + 
MDP 
Group III : Animals immunized with particulate antigen 
fraction + MDP 
Group IV : Animals immunized with MDP only-
Each hamster was given intraperitoneal1y , a dose 
containing 0.2 mg antigen with 450 Ajg of MDP at 4 day 
intervals. A total of four infections were given for each 
animal. The inoculum in each injection was made up to 0.5 ml 
with the addition of saline. The number of hamsters in each 
group was 25. Eight animals randomly selected from each group 
were bled in the 2nd, 4th and 6th week after the last 
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immunizing injection. The immunization schedule is shown in 
Table II. 
7.3 Detection of Hutnoral Immune Responses 
The sera samples obtained from different groups of 
immunizing animals were tested for the presence of specific 
anti L. donovani antibodies by means of IHA and ELISA tests. 
(A) Indirect Haemagglutination Test (IHA) 
This test was done according to the method of Mathews 
et. al . ( 1975). A 3* suspension of sheep red blood cells 
(SRBC) was tanned with tannic acid (1:20,000) for 30 minutes 
at 4°C. The tanned cells were sensitized with antigen at 37°C 
for 30 minutes. The cells were added to two fold dilutions 
of the serum. The highest dilution of serum showing a 
positive reaction was recorded as the titratran end point. 
(B) Enzyme Linked Immunosorbent Assay (ELISA) 
This test was performed according to the method of Lin 
et al. (1981) with slight modifications. Anti-hasmter IgG 
alkaline phosphatase conjugate used in the test was prepared 
as follows: 
(i) Isolation of Immunoglobulin G (IgG): 
The serum was obtained from hamsters blood. The IgG was 
precipitated at 40% saturated ammonium sulphate. The 
precipitate was washed three times alternatively with 
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distilled water and ammonium sulphate. The precipitate was 
dissolved in normal saline and potassium phosphate buffer, 
pH 6.3. The immunoglobulin G was purified on DEAE cellulose 
anion exchanger according to the method of Sober et al . 
(1956). The protein concentration was estimated according to 
the method of Lowry et al. (1951). 
(ii) Production of Anti-hasmter IgG: 
Three healthy rabbits were immunized with purified 
hamster IgG, intravenously. Control animals were inoculated 
with saline only. The immunization schedule was completed 
over a period of seven days in three inoculations. After the 
last immunizing dose, maximum antibody titres were detected 
by counter immunoelectrophoresis at weekly intervals. The 
immunization schedule is shown in Table III. 
Counter immunoelectrophoresis was carried out according 
to the method of Bjerrum and Bog Hansen (1976) with slight 
modifications. About 3 ml of 0.8 percent agarose gel prepared 
in 0.025 M barbital buffer, pH 8.6 containing 0.1 percent 
soidum azide was layered over glass slides of 25 mm x 75 mm 
size. Agarose was allowed to solidify at room temperature and 
the slides were kept overnight at 4°C. A set of 2 mm wide 
wells (5 mm apart) were punched in the agar. Cathodal wells 
were filled with antigen samples, while anti-hamster IgG 
antiserum was filled in the anodal wells. Electrophoresis 
was carried out for 3 hours at a constant current supply of 
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7 mA per slide at 150 volts. After electrophoresis, the 
slides were incubated at room temperature for 4 to 5 hours 
in a humid chamber. After incubation the resolved precipitin 
bands were later recorded. 
The anti-hamster IgG was isolated on diethyl amino 
ethyl cellulose (DEAE) anion exchanger prepared according to 
the method of Sober et al ( 1956). About 2 mg of anti-
hamster IgG in 0.1 ml PBS was added to 5 mg of alkaline 
phosphatase and mixed at room temperature. The mixture was 
dialysed extensively against PBS at 4°C. Later Glutaraldehyde 
was added to give a final concentration of 0.23^  of the above 
mixture and incubated for 1 to 2 hours at room temperature. 
After incubation it was dialyzed against PBS at then 
against 0.05 M Tris (hydroxymethyl aminomethane) buffer (pH 
8.0 at 4°C. To remove the insoluble materials, the solution 
was centrifuged at 5000 rpm for 10 minutes. The supernantant 
was diluted with. Tris buffer containing 0.02X sodium azide 
and 1.0% fetal calf serum. The conjugate was stored in the 
dark at 4°C until used. 
(iii) Preparation of Reagents: 
1. Coating buffer: 
An 0.05 M carbonate - bicarbonate buffer containing 
0.02% sodium azide was prepared in distilled water. The pH of 
the solution was adjusted at 9.6. 
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2. Phosphate buffer saline - Tween 20: 
A solution containing 0.154 M PBS containing 0.05% 
Tween 20 (v/v) was prepared (pH 7.4). 
3. Diethanolamine buffer: 
A 10% diethanolamine containing 0.01% MgCl2. 6H2O and 
0.02% sodium azide was prepared (pH 9.8). 
4. Substrate: 
One tablet of p-nitrophenylphosphate was dissolved in 5 
ml of 10% d i ethano 1 ami ne buffer and warmed at room 
temperature. 
The ELISA test was performed in flat microtitre 
plates. The plates were coated with 20 xjg antigen protein in 
carbonate buffer in each well. The plates were incubated at 
37°C in a water bath for 6 hours at 4®C and kept overnight. 
The plates were there washed thrice with phosphate buffered 
saline containing Tween 20. The above plates were reacted 
with 0.2 ml BSA solution (100 mg/ 100 ml) for 1 hour and kept 
at 37°C. The plates were again washed and to react with 0.2 
ml of serially diluted test serum which was added to each 
well and incubated for 2 hrs at 37°C. After incubation, the 
plates were again washed three times. An 0.2 ml of anti-
hamster IgG alkaline phosphate conjugate (1:400 dilution with 
PBS/T) was added to each well. The plates were incubated for 
2 hours at 37°C. The plates were again washed three times 
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with PBS/T. An 0.2 ml substrate was added to each well. 
After 30 minutes incubation, the reaction was stopped by 
adding 0.05 ml of 3 N NaOH. The colour intensity was measured 
after 15-20 minutes at a wave length of 400 nm using a Bausch 
and Lomb Spectronic - 21 Spectrophotometer. 
7.4 Haematological studies 
(a) TotaT Leukocyte Count (TLC) 
Total leukocyte counts were made according to the 
method described by Dacie and Lewis (1970) for the detection 
of circulating peripheral leukocytes. The blood samples from 
the immunized animals were collected in the 2nd, 4th and 6th 
week after the last immunizing dose. The blood samples were 
collected in white blood cell counting pipettes upto 0.5 mark 
and diluted with Turk's fluid (3X glacial acetic acid in 
distilled water) to which methylene blue in small amount was 
also added. The leukocytes were counted in a 
haemocytometer. 
(b) Differential Leukocyte Count (DLC) 
The differential leukocyte counts were made according 
to the method described by Dacie & Lewis (1970). Blood 
samples from immunized animals were collected in the 2nd, 4th 
and 6th week after the last immunizing dose. 
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7.5 Detection of Cell-Mediated Immune (CMI) REsponses 
Cell-mediated immune responses in all the immunized 
animals were detected in vivo by means of delayed types 
hypersensitivity (DTH) reactions as according to the method 
described by Cook and Holbrook ( 1 983 ). The DTH 
responsiveness was monitored by giving foot pad injections 
of washed promastigotes suspended in 0.5X phenol-saline 
(0.025 ml, 2.0 x 10® ml). The thickness of the inoculated 
foot-pad was measured by using dial calipers (IME England) 
at 24 hours following injection. The results were expressed 
as percent increase in footpad thickness when compared with 
the uninjected foot. 
8. Protection Studies 
Four weeks after immunization, all immunized animals 
vaccinated with samples of whole antigen, soluble and 
particulate antigen (with or without MDP) were subsequently 
challenged with lethal doses of viable L. donovani 
promastigotes. Each animal received an intra-peritoneal 
challenge dose containing 1 ml of 1 x 10^ promastigotes. The 
promastigotes used for injecting the animal, were harvested 
from the overlay of BHMARB medium during the log phase of 
growth. The parasites harvested by centrifugation at 1200xg 
for 30 minutes were suspended in HBSS at the desired 
concentration. The promastigotes used for such infection were 
passaged in vitro no more than 6 times. The survival time for 
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each hamster was also recorded. Blood samples from the 
protected as well as unprotected hamsters were obtained for 
subsequent investigations of humoral and cell-mediated immune 
responses. 
8.1 Detection of Humoral Immune Responses 
Four animals randomly selected from each group were 
bled through heart in the 2nd, 4th and 6th week after 
challenge. The serum samples collected during post-challenge 
period were tested for the production of specific anti-
Leishmania antibodies by Indirect Haemagglutination (IHA) 
tests and Enzyme-Linked Immunosorbent Assays (ELISA) as 
described earlier. 
8.2 Haematological studies 
Total leukocyte counts (TLC) and differential counts 
(DLC) were made in blood samples obtained in the 2nd, 4th and 
6th week after challenge. The above blood samples were 
collected in vials containing EDTA as an anticoagulant. These 
tests were made according to the methods described by Dacie 
and Lewis (1970). 
8.3 Detection of Cell-mediated Immune Responses (CMI) 
The delayed type skin hypersensitivity reactions (DTH) 
and macrophage migration inhibition tests (MMIT) were 
employed for the assessment of CMI response. 
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(A) Skin Test 
Footpad swelling in response to phenol suspension of 
promastigotes was used as an index of cellular immune 
responsiveness. This test was carried out according to the 
method described by Cook and Hoi brook ( 1983). 
(B) Macrophage Migration Inhibition Test (MMIT) 
Capillary migration inhibition test was performed 
according to the published procedure of Bloom and Bennett 
(1971), Following challenge, animals showing positive DTH 
reaction from each experimental group (with or without MDP) 
were injected intraperitonea11y with 10 ml of sterile 
paraffin oil. After 48 hours animals were sacrificed and 
their peritoneal cavities washed with heparinized Hanks 
balanced salt solution (5 lU/ml). The peritoneal fluid was 
collected into a separating funnel and allowed to settle for 
one hour. The aqueous phase was then separated from oil phase 
by centrifugation at 1200 rpm for 10 minutes at 4°C using 
sterile disposable plastic centrifuge tubes. The supernatants 
were separated and the cells were pooled and washed by HBSS 
for two times. After the last washing, the cells were 
suspended with RPMI 1640 (GIBCO) medium containing penicillin 
(100 units/ml) and streptromycin (100>ug/ml) as antibiotics. 
The cells were counted in a haemacytometer. The viability of 
the cells was determined by 0.2 percent trypan blue dye 
exclusion test. The viability was not less than 95%. The 
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peritoneal exudate cells were adjusted at a concentration of 
3 X 10® cells/ml. These cells were filled in 75 ul capillary 
tubes (1.1 mm internal diameter). The capillary tubes were 
sealed with sterile plasticin at one end and centrifuged at 
800 rpm for 10 minutes. Then they were cut at cell-fluid 
interface and placed in Mackaness migration chambers 
containing RPMI 1640 medium with 15 ug/ml antigen protein. 
Foetal calf serum (10%) and antibiotics (streptomycin and 
benzyl penicillin) were also added to the filled chambers. 
The control chambers were devoid of Leishmania antigen. The 
cells were allowed to migrate for 48 hours at 37°C within an 
atmosphere of 5% COg in COg incubator (New Burnswick 
Scientific, U.S. A Model CO-20). The area of migration in 
control, as well as the antigen chambers, was recorded on a 
graph sheet with the help of camera Lucida. The percent 
migration inhibition was calculated as follows: 
Migration area with antigen 
% Migration Inhibition = x 100 
Migration area without antigen 
8.4 Organ Impression Smears 
In the 2nd, 4th and 6th week after challenge, 4 animals 
from each treatment group were killed in ether. The 
impression slides from spleen and liver tissues were made by 
lightly dabbing the cut surface of the organ on clean,micros-
copic slides. The slides were air dried, fixed in absolute 
methanol and stained with Leishman stain. The parasite 
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burden in these tissues were determined by the method of 
Stauber (1966). About 1000 or 500 cell nuclei were counted. 
The ratio of amasti gotes/cel 1 nuclei was calculated and 
multiplied first by the weight of the organ in milligrams, in 
order to determine the parasite load in Leishman Donovan 
units (LDU). The above number was then multiplied by 2 x 10® 
to arrive at an approximate absolute number of parasites per 
organ. 
8.5 Light Microscopic Studies 
Regents 
1) Neutral buffered formalin 10%, (Lillie, 1948) 
Commercial formalin (37-40% formaldehyde) 100 ml 
Distilled water 900 ml 
Sodium dihydrogen phosphate (NaH2 PO^ H2O) 4.09 gm 
Disodium hydrogen phosphate (NaHPO^^ HgO) 6.5 gm 
The solution was neutralized by keeping it over calcium 
carbonate before use. 
2) Graded strengths of Ethanol: Various strengths of ethanol 
were obtained by diluting a higher grade ethanol (rectified 
spirit or absolute ethanol) with distilled water. For making 
a given strength of ethanol, the required percentage was 
substracted from the ethanol percentage out of which 
dilutions were to be made. The difference between the two 
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percentages gave the amount of distilled water required to 
be added for obtaining a particular dilution. 
3) Mayer's Egg Albumin: The white of an egg was taken in a 
measuring cylinder, and mixed with an equal volume of pure 
glycerine. After a through mixing, a crystal of thymol was 
added to the solution, and the solution was kept in a glass 
stoppered bottle and stored in a refrigerator. 
Processing of Tissues for Making Paraffin Blocks 
The Liver and spleen of both normal and experimental 
hamters were gently transferred into sufficient quantity of 
30% ethanol. The parts were then processed through increasing 
strengths (50, 70, 80, 90 and 95 percent) of ethanol by 
keeping them in each grade for 1 hr. Dehydration was 
completed by two changes of absolute ethanol, each of 30 
min. duration. Dehydrated specimens were cleared with xylene 
(2 to 3 hrs) and infiltrated with parafin wax (56°C melting 
point). The filtered molten wax was poured into a paper-mould 
and with the help of a forceps (warmed over flame), the 
impregnated slices were quickly placed. Tissue orientation 
was done immediately after placing a particular organ piece 
inside the mould. Rapid cooling helped in the solidification 
of wax. The paraffin blocks thus obtained were labelled and 
f stored in a refrigerator till used for section cutting. 
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Cutting of Paraffin Sections 
The paraffin blocks were trimmed and attached to block 
holders. After routine adjustments, 4-5 /j mm thick sections 
were cut with a sharp knife of a rotary microtome. The 
ribbons of sections were spread on a sheet of paper over a 
flat surface. 
Attachment of Section on Glass slides 
Small lengths of ribbons were cut by a sharp razor 
blade. They were lifted by a spatula and transferred to the 
water surface in a tissue floatation bath, the temperature of 
which was always kept about 1 to 2 degrees below the melting 
point of wax used. The flattened sections were carefully 
lifted and placed on clean glass slides smeared with a thin 
layer of egg albumin. The slides were kept overnight in an 
incubator adjusted between 40 to 45°C. The dried slides were 
then ready for staining. 
Haematoxylin Eosin Staining 
Reagents 
1) Harri's Haematoxylin 
Haematoxylin 10 gm 
Absolute (or 95X) ethanol 10 ml 
Potash alum 20 gm 
Distilled water 200 ml 
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The haematoxy1in was dissolved in ethanol and added to 
a solution of potash alum in hot water. After thorough 
mixing, the solution was boiled and mercuric oxide was added. 
It was rapidly cooled under tap water and filtered into the 
stock solution. 
ii) Alcoholic Eosin (ISg) 
Eosin (alcohol soluble) 1 gm 
Ethanol (90%) 100 ml 
After dissolving the dye, the solution was filtered 
through a Whatman's No.2 filter paper and stored in an 
airtight bottle. 
Procedure 
The slides were deparafinized with xylene and 
transferred to absolute ethanol. They were processed through 
descending strengths of ethanol, keeping in each grade for 
about a minute. Finally, they were hydrated with distilled 
water before being placed in haematoxylin for 3 to 5 mm. 
Differentiation of tissues was done with 0.5 percent 
hydrochloric acid solution, the colour intensity was 
monitored in an optical microscope. 'Blueing' was achieved 
by rinsing the slides in weak alkaline water and the 
intensity of stain rechecked. After haematoxylin staining, 
the slides were dehydrated by processing them for about 2 
min. each, in ascending grades of ethanol upto 90 percent. 
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They were then dipped for 30 to 45 sec. in the alcoholic 
eosin solution. After a orief rinse in 90 percent ethanol, 
the slides were finally dehydrated in absolute ethanol; 
cleared in xylene; and mounted in Canada balsam. 
8.6 Pathological studies 
The different vaccinated animal from various groups 
alongwith controls, were sacrificed in the 2nd, 4th and 6th 
week after challenge, for making gross observations of liver 
and spleen. These organs were excised and fixed in 10% 
formalin saline. The excised organs were sectioned and 
processed for detailed histological studies. The slides were 
stained with iron hematoxylin and eosin (H&E) and later 
examined microscopically. 
RESULTS 
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RESULTS 
1. In Vitro Culture of Leishmania donovani 
The cell line (NICD: C-II strain) was cultured in Brain 
Heart Infusion Agar medium with rabbit blood (BHMARB). Hank's 
balance salt solution was used as an overlay. No antibiotic 
was added to the medium. The cultures were generally seeded 
with 1.7x10® parasites (0.1 ml) per 3 ml of overlay. Parasite 
counts were carried out at 24,48,72,96,120,144,160,192, and 
216 hours. The rate of multiplication was found to be 
satisfactory in the above medium. The promastigote count in 
BHMARB was found to increase from 5.8x10®/ml to 8.7x10® ml in 
24 hours. The maximum parasite growth was obtained at 144 
hours, which further showed no increase in the promastigote 
count even after longer hours of incubation. The decrease in 
parasite count was seen after 168 hours of incubation. The 
maximum multiplication was 10.83 after 96 hours of 
incubation. The multiplication rate of promastigotes in 
BHMARB medium was about 379.31 times after 6 days of 
incubation (Table IV). 
2. Antigen Preparation 
L. donovani promastigotes obtained from 6 day old 
cultures, free from contaminants, were pooled and subjected 
to six successive washings in normal saline to which 
gentamycin was added. The washed promastigotes were then 
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Figure 1 : Growth curve of L. donovani promastlgotes in 
medium. The counts were made at 24 hr. period. 
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Figure 2 : Photomicrograph showing leishman stained L. donovani 
promastlgotes from a 6 day old culture in BHMARB 
medium ( X 1000 ) . 
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osmolysed in double distilled water. The osmolysed 
suspensions represented the v.'hclG antigen frorn L, donovani 
promastigotes. The above preparation was checked under the 
microscope for complete cell lysis. The osmolysis generally 
resulted in 100?^  cell lysis. 
3. Fractionation of Whole Antigen 
The osmolysed suspension from L. donovani promastigotes 
in double distilled water representing whole antigen was 
subjected to centrifugation at 105,000 x g for one hour. The 
supernatant thus obtained represented the soluble antigen 
fraction, while the deposit represented the particulate 
antigen fraction. The smears were made from each fraction 
after ultrasonication showed that they were completely 
homogenized. 
4. Biochemical Characterization of Antigen 
4.1 Protein Concentration 
Protein concentrations in whole antigen, soluble and 
particulate antigen fractions were estimated according to the 
method of Lowry et al. (1951) as 3.41 mg/ml, 1.2 mg/ml and 
1.74 mg/ml respectively. The result are shown in Table V. 
4.2 Carbohydrate Concentration 
Carbohydrate concentrations in whole antigen, soluble 
and particulate antigen fractions, as estimated according to 
the method of Dubois et, al . (1956) were 1.62 mg/ml, 0.22 
102 
mg/ml and 0.61 mg/ml respectively. The results are shown in 
Table V. 
4.3 DNA Concentration 
The DNA concentrations per ml of whole antigen, soluble 
and particulate antigen fractions, estimated according to the 
method of Burton (1956) were 0.96/Ug/ml, 0.06 ^ig/ml and 0.85 
/Ug/ml. The results are shown in Table V. 
4.4 Molecular Weight Determination 
Sodium dodecyl sulphate po1yacry1 amide gel 
electrophoresis (SDS-PAGE) was used for the separation of 
protein subunits of L. donovani promastigote antigen 
fractions, and for determination of the molecular weights 
according to the method of Laemmli (1970) (with slight 
modifications). Four protein bands each were resolved for 
whole and particulate antigen fractions while two protein 
bands were resolved for soluble antigen fraction. Molecular 
weight estimations for proteins were carried out after 
calibrating the gels with a mixture of molecular weight 
marker proteins. The results are shown in Table VI. 
5.0 Antigenicity Testing 
5.1 Indirect Fluorescent Antibody (IFA) Test 
Indirect fluorescent antibody test was carried out 
according to the method of Abdalla (1977) for checking the 
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Figure 3 : SDS-PAGE profile of L. donovani promastigote 
antigens. Molecular weights of marker proteins 
are indicated. 
MP - Marker Protein 
I - Whole antigen 
II - Soluble antigen 
HI - Particulate antigen 
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antigenicity of the isolated antigen fractions. Positive 
human sera samples were used against the above antigen 
preparations, The sera employed for this purpose were first 
subjected to antibody assays by IFA test. 
5.2 Indirect Haemagglutination (IHA) Test 
Indirect haemagglutination test was done according to 
the method of Mathews et, al . ( 1 975 ) for checking the 
antigenicity of the whole antigen fraction. An antigen 
dilution of 1:16 was found to be the optimum working dilution 
for use in IHA tests. All the antigen titrations were carried 
out against a known positive human sera sample. The highest 
antibody titre value was 1:2048 as obtained from the positive 
human sera sample. The results are shown in Table VII. 
5.3 Agar Diffusion Technique 
Agar gel diffusion technique was used for testing the 
antigenicity of whole, soluble, and particulate antigens 
fraction against the Kala-azar positive human sera samples. 
All the above antigen preparations showed well defined 
precipitation lines between the antigen and the antisera. 
6. Immunization Studies 
6.1 Detection of Humoral Immune Response in Immunized Animals 
Humoral immune responses were detected in different 
experimental groups of golden hamsters immunized with whole, 
Figure 4 : A precipitation reaction profile of antigen fractions 
versus human antisera. 
A. Whole antigen versus human antiserum (Central 
well - Antiserum, Peripheral well - Whole Antigen). 
B. Partculate antigen versus human antiserum 
(Central well - Antiserum, Peripheral well - Parti 
-culate antigen). 
C. Soluble antigen versus human antiserum (Central 
well - Antiserum , Peripheral well - Soluble 
antigen). 
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soluble and particulate antigen fractions only and then in 
combination with MDP. The sera samples obtained from 
different groups of immunizing animals were tested for the 
presence of specific anti L. donovani antibodies by means of 
IHA and ELISA tests. 
1. Detection of Humoral Immune Response by Indirect 
Haemagglutination (IHA) Tests 
Serum samples from the animals immunized with whole, 
soluble and particulate antigen fractions showed they slight 
changes in the antibody titres (Table VIII). No antibodies 
were detected in control animals which separately received 
saline and MDP only. Serum samples from the animals 
immunized with whole antigen and MDP showed a highest 
reciprocal titre value of 512 in the 6th week after the last 
immunizing dose. The reciprocal titre value was 32 in animals 
immunized with soluble antigen and MDP in the 6th week after 
immunization. Reciprocal titre value was 256 in animals 
immunized with particulate antigen and MDP in the 6th week. 
Results on specific antibody detection by the IHA tests are 
shown in Table IX. 
2. Detection of Humoral Immune Response by ELISA 
Serum samples obtained from animals immunized with 
whole, soluble and particulate antigen fractions showed 
slight rise in the antibody titres (Table X). No antibodies 
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were detected in control ammals which received saline, or 
MDP only. Serum samples from animals immunized with whole 
antigen and MDP showed a highest reciprocal titre value of 
2048 in the 6th week after immunization. Similarly, the 
reciprocal titre value was 256 in animals immunized with 
soluble antigen and MDP in the 6th week following 
immunization. The animals immunized with particulate antigen 
and MDP showed a titre of 1024 in the 4th week after the last 
immunizing dose. These results are shown in Table XI. 
6.2 Haematoleg1cal Studies 
(A) Total Leukocyte Count (TLC) 
Animals immunized with whole antigen or its fractions 
showed slight change in TLC picture. The average TLC in 
control animals was 3441.66 mm (Table XII). However, higher 
TLC values were recorded in animals immunized with whole 
antigen, or its fraction in combination with MDP. The 
control animals which were given MDP only also showed an 
increase in their TLC values (Table XIII). Without adjuvant, 
the increased TLC were observed as early as in the second 
week after immunization and these increases were not 
appreciably altered thereafter. Immunization with MDP 
adjuvant or MDP alone induced gradual increases in TLC with 
time. 
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(B) Differential Leukocyte Count (DLC) 
(i) Polymorphonuclear leukocyte: 
The blood from animals immunized with whole antigen 
showed no significant change in the percentage of polymorphs 
in the second week after the last immunization dose. The test 
animals in this group had an average count of 41,25 percent 
in comparison with normal average count of 44.50 percent. 
While all those animals which were immunized with soluble 
antigen sample and particulate antigen fraction showed 
decrease in their polymorph counts (Table XIV). The blood 
count values were approximately the same in the fourth week 
after immunization. Animals immunized with whole antigen 
showed an average count of 42.50 percent while those 
immunized with soluble and particulate antigen fraction had 
an average count of 19.75 and 33.00 percent, respectively. 
In the sixth week after the last immunization dose the above 
animals (except those which were given whole antigen) showed 
an average count varying from 22.50 to 26.75 percent as shown 
in Table XIV. All the animals which were immunized with 
parasite antigens in combination with MDP showed no 
significant change in the percentage of polymorphs when 
tested in the second week after the last immunization dose 
(Table XV). In the fourth week, animals immunized with whole 
antigen MDP, soluble antigen MDP and particulate antigen + 
MDP showed an average count of 38.50, 30.75 and 36.50 percent 
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respectively. While those animals which were given MDP only 
showed sn styGfO-Q© count o f 43.25 percent. In the sixth week 
the above animals (also the MDP group) showed no significant 
change in their polymorph counts when compared with the 
normal average count (Table XV). 
(i i) Lymphocytes 
The lymphocyte counts in the second week following the 
last injection were more or less normal in the animals 
immunized with whole antigen. This group had an average 
count of 57.25 percent as compared with normal average count 
of 50.75. But the animals immunized with soluble and 
particulate antigen showed an increased in lymphocyte counts 
at around the same time (Table XIV). In the fourth week, 
animals given whole antigen showed an average count of 54.75 
per cent, while those given soluble and particulate antigen 
had an average count of 77.50 and 2.75 percent respectively. 
In the sixth week after immunization, the above animal groups 
(except those given whole antigen) also showed an increase in 
lymphocyte counts when compared with the average count from a 
normal animal (Table XIV). 
All the animals which were given parasite antigens only 
in combination with MDP showed an increase in lymphocyte 
counts when tested in the second week after immunization. The 
results are shown in Table XV, In the fourth week after 
119 
immunization, animals given whole antigen + MDP, soluble 
antigen + MDP and particulate antigen + MDP showed an average 
counts of 60.25, 63.75 and 59.75 percent, respectively. 
Animals receiving MDP only showed an average count of 53.50 
percent, respectively. Animals receiving MDP only showed an 
average count of 53.50 percent. In the sixth week after 
immunization, the above animal groups (except those given MDP 
alone) also showed an increase in the lymphocyte counts 
compared to the normal average count (Table XV). 
(ill) Monocyte and Eosinophil 
No significant changes were recorded in monocyte and 
eosinophil counts among the animal groups immunized with 
parasite antigen (with or without MDP). Parallel control 
animals (given MDP alone) did not show any change either in 
the second, fourth and sixth week after immunization. 
6.3 Detection of Cel1-mediated Immune Response 
The delayed type hypersensitivity response (DTH) 
manifested as footpad swelling following the administration 
of phenol suspended promastigotes was negative in all the 
groups receiving whole, soluble and particulate antigen 
fractions, alone or in combination with MDP. The animals were 
tested in the second, fourth and sixth week following the 
last immunizing injection
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7. Protection Studies 
Four weeks after immunization, all the animals 
vaccinated with samples of whole, soluble and particulate 
antigens alone and in combination with MDP, were subsequently 
challenged with lethal doses of viable L. donovani 
promastigotes. 
7.1 Detection of Humoral Immune Responses in Challenged 
Animals 
Serum samples obtained from the challenged animals were 
employed for the detection of L. donovani specific antibodies 
by means of IHA and ELISA tests. 
1. Indirect Haemagglutination (IHA) Test 
Serum samples from the animals immunized with whole 
antigen showed the reciprocal titre value of 512 in the 6th 
week after the challenge. But animals which received soluble 
and particulate antigen preparations showed average 
reciprocal titre values of 32 and 128 respectively in the 6th 
week after the challenge (Table XVI). Animals immunized with 
whole antigen and MDP showed the highest reciprocal titre 
value of 1024 in the 6th week after challenge. The animals 
which received soluble and particulate antigen preparations 
with MDP showed the reciprocal titre values as 64 and 256 
respectively in the 6th week after the challenge. These 
results are shown in Table XVII. 
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2. Enzyme Linked Immunosorbent Assay (ELISA) 
The results of ELISA test are shown in Table XVIII & 
XIX. Animals immunized with whole antigen alone showed the 
highest reciprocal titre of 1024 in the 6th week after the 
challenge. While animals immunized with soluble and 
particulate antigen samples showed the maximum titre values 
of 128 and 512 respectively in the 6th week following 
challenge (Table XVIII). Animals which received whole antigen 
in combination with MDP showed maximum titre value of 2048 
in the 6th week after the challenge. However animals 
immunized with soluble and particulate antigen preparations 
with MDP showed the titre values of 256 and 1024 
respectively, in the 6th week following challenge (Table 
XIX). 
7.2 Haematolegical Studies: 
(a) Total Leukocyte Count (TLC) 
After challenge all those animals which were inoculated 
with different parasite antigen sample, alongwith controls, 
showed leukopenia. This was confirmed by matching the TLC 
values obtained from uninfected animals (Table XX). The 
challenged animals (immunized with parasite antigens in 
combination with MDP) showed Leukocytosis. However, the TLC 
count in these animals decreased in the second, fourth and 
sixth week after challenge. The results are shown in Table 
XXI. 
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(b) Differential Leukocyte Count (DLC) 
(i) Polymorphonuclear Leukocyte: 
All the animals immunized with parasite antigens alone 
showed a decrease in percentage of polymorphonuclear 
leukocytes when tested in the second, fourth and sixth week 
after the challenge. In the second week after the challenged, 
the animals given whole antigen, soluble and particulate 
antigen showed an average count of 27.25, 23.50 and 26.50 
percent, respectively. These values were compared with the 
normal average count of 44.50 per cent. The control animals 
which received saline only showed an average count of 27.25 
percent following challenge. The results are shown in Table 
XXII. In the fourth week, animals which were immunized with 
whole antigen, soluble and particulate antigen showed slight 
increase in the average count percent, respectively. In the 
sixth week after the challenge there was also a decrease in 
polymorph counts in immunized animals, as compared with the 
normal average count. All the challenge animals immunized 
with parasite antigens in combination with MDP showed a 
decrease in polymorph counts in the second, fourth and sixth 
week after challenge. The results are shown in Table XXIII. 
(i i) Lymphocyte Count 
The lymphocyte counts were found to increase in animals 
immunized with parasite antigens in the second, fourth and 
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sixth week after the challenge. The normal average count was 
around 50 percent. In the second week, the animals given 
whole antigen, soluble and particulate antigen showed an 
average counts of 69.25, 72.50 and 68.75 percent 
respectively. The control animals which received saline only 
upon challenge also showed an increase in lymphocyte count. 
The results are shown in Table XXII. The animals immunized 
with parasite antigens in combination with MDP also showed an 
increase in lymphocyte count as compared with the normal 
average count. The results are shown in Table XXIII. 
(iii) Monocytes and Eosinophils 
Little increase was observed in the overall percentage 
of monocytes in the animals immunized with parasite antigen 
(with or without MDP) compared with normal animals, 
following challenge. No significant changes were observed in 
the percentage of eosinophils in the various animal groups 
compared with normal animals. 
7.3 Detection of Cell-mediated Immune Responses in Challenged 
Animals 
1. Footpad Swelling 
Footpad swelling, a measure of delayed type 
hypersensitivity response (DTH), following administration of 
phenol suspended promastigotes was negative in all the groups 
which received parasite antigen samples alone. The above 
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tests were carried out in the second, fourth and sixth week 
after the challenge. The animals receiving parasite antigens 
in combination with MDP showed positive DTH responsiveness in 
the second, fourth and sixth week after challenge. The DTH 
response in animals given whole antigen and MDP was 
significantly greater than the groups which received other 
antigen preparations in combination with MDP. Control animals 
given MDP alone showed a negative DTH response. The results 
of DTH responses are shown in Table XXIV. 
2- Macrophage Migration Inhibition (MMI) 
The results of macrophage migration inhibition are 
shown in Table XXV. Animals immunized with whole antigen in 
combination with MDP showed maximum migration inhibition of 
4 5 . T h e MMI values in animals immunized with soluble and 
particulate antigen plus MDP were 3 1 . a n d 39.25X 
respectively. Macrophage migration inhibition values from 
animals which received MDP alone and saline only were not 
significant. 
7.4 Organ Impression Smears 
In the 2nd, 4th, 6th and 8th week after challenge, 4 
animals from each test group were killed by ether. The 
impression slides from spleen and liver tissues were made to 
determine the parasite burden. In control hamsters and the 
hamsters immunized with parasite antigens only, the splenic 
and hepatic parasite count was observed to increase in the 
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4th week after challenge. Animals which received parasite 
antigen in combination with MDP showed significantly reduced 
parasite burden both in the splenic and hepatic counts after 
the challenge. This was in total contrast to animals which 
were given parasite antigens only, where no such reduction 
was observed. Animals receiving whole antigen in combination 
with MDP showed significant reduction in the splenic and 
hepatic parasite count in the post challenge period. The 
control animals given MDP alone also showed a decrease in 
splenic and hepatic parasite counts during the post 
challenge period. These results are depicted in Tables XXVI 
& XXVII. 
7.5 Pathological Studies 
The vaccinated animals alongwith the controls were 
sacrificed in the 2nd, 4th, 6th and 8th week after challenge 
for examining the histopathologic changes in liver and 
spleen. After challenge, the animals of the control group and 
those immunized with parasite antigen only showed decrease in 
activity and loss of appetite. Animals which were immunized 
with parasite antigen in combination with MDP and MDP only, 
were less active and showed a definite loss of appetite. 
Parasites were detected in the peripheral blood of animals 
treated with saline in the 4th and 6th week showing spleen 
enlargement. But the liver remained unchanged in the control 
animals in the 4th week after challenge. However, in the 6th 
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Figure 5 : Photomicrograph of spleen and liver from a normal 
animal. 
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Figure 6 : Photomicrograph of spleen and liver from a control 
hamster following challenge. 
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Figure 7 : Photomicrograph showing spleen and liver from 
a protertPd hamster Immunized with whole antigen. 
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Figure 8 : Liver section from a normal animal ( H a E X 
100 ). 
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Figure 9 : Liver section as seen in higher magnification from 
a normal animal (H 8 E X 200). 
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week after challenge, both the spleen and liver were 
prominently enlarged comparea to the normal animals. 
Liver: 
During the 2nd week after infection there were immature 
granulomas consisting of hypertrophied macrophages and 
lymphocytic elements scattered randomly throughout the 
parenchyma (Fig.10 & 11). Kuffer cells with abundant 
parasites were also seen. The proliferation and 
parasitization of macrophages and endothelial cells steadily 
increased in intensity. In the 4th and 6th week after 
challenge portal spaces showed a marked increase in 
macrophages surrounding the veins, ducts and arteries, 
besides the numerous parasitized Kuffer cells. In the 8th 
week after challenge, the portal spaces and sinusoids showed 
further accumulation of macrophages. The liver cells 
appeared atrophied and the architecture was distorted 
compared to the normal liver cells. A few mitoses are seen 
among the liver cells. 
The animals immunized with parasite antigens alone 
presented a more or less similar picture in the 2nd week 
after infection. There was a marked accumulation of 
macrophages in the portal spaces, besides the sinusoides 
which were unevenly dilated with hyperplasia of endothelial 
cells and Kuffer cells, showing parasites. The liver cells 
Figure 10 : Liver section from an infected control animal showing 
granulomatous lesions containing hypertrophied 
macrophages (H8E X 200). 
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Figure 11 : Liver section from an infected control animal as 
seen in higher magnification showing kupffer cells. 
Th3 arrow indicates the L.D bodies (HSE X 400). 
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Figure 12 : Liver section from an infected control animal as 
seen in higher magnification showing L.D bodies. 
The arrow indicate the L.D bodies inside kupffer 
cells (HSE X 1000). 
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Figure 13 : Infected kupffer cells showing numerous L.D bodies. 
The arrow indicate the L.D bodies (HSE X 1000). 
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were atrophied and showed marked apoptotic changes. In the 
4th and 6th week after challenge the pro1iferation of 
macrophages and kuffer cells increased, Kuffer cells showed 
numerous parasites. The liver cells were atrophied with 
distorted architecture. 
The animals immunized with parasite antigen 
preparations in combination with MDP showed granuloma lesions 
and accumulation of macrophages in the portal spaces in the 
6th week after challenge. Kuffer cells showed only few 
parasites. In the 8th week after challenge, further 
accumulation of macrophages with hyperplasia of endothelial 
cells was seen. The animals which received whole antigen in 
combination with MDP showed comparatively fewer macrophages 
with few parasites only (Fig.14). 
Spleen 
The cut sections of spleen from the saline controls 
and animals immunized with parasite antigen showed 
accumulation of macrophages in the red pulp in the 2nd week 
after challenge. Additionally, there was a diffuse 
hypertrophy of the white pulp. No granuloma formation was 
evident. Few macrophages containing parasites were located 
within the red pulp. In the fourth week after infection the 
picture was somewhat similar but slightly more advanced. The 
splenic architecture was preserved and there was an increased 
number of parasitized macrophages in both red and white pulp. 
Figure 14 : Liver section from an animal immunized with wholw 
antigen + MDP (H 8 E X 400). 
m 
Figure 15 : Photograph showing atrophy of hepatic cells with 
prominent distortion of liver architecture 
(H S E X 100). 
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Figure 16 : Liver section in higher magnification shov/inp 
accumulation of macrophages with no parasites 
(H S E X 1000). 
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Figure 17 : Spleen section from a normal animal 
(H Q E X 100). 

Figure 18 : Spleen section as seen in higher magnification 
from a normal animal (H a E X 400). 
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In the 6th & 8th week after challenge the histological 
picture was more or less similar with numerous foci of 
tissue necrosis. The white pulp was extensively invaded by 
parasitized macrophages. No mitotic figures were seen either 
in the pulp or the splenic corpuscles. The hyperplasia of 
white pulp with sinusoidal dilation was also prominent 
(Fig.l'l & 2,0). The animals immunized with parasite antigen in 
combination with MDP showed proliferation of macrophages in 
the red pulp with hyperplasia of the white pulp in the 2nd 
week after infection. Few macrophages containing parasites 
were also located. However in the 4th week, the picture was 
more or less similar with slightly more prominent changes. In 
6th and 8th week after infection, there was a marked 
proliferation of macrophages, with only few parasitized cells 
(Fig.23). A fibrous reaction was also seen in these tissues. 
Figure 19 : Spleen section from an infected control animal 
showing white pulp invades with macrophages 
(H 8 E X 200). 
157 
Figure 20 : Spleen section from an infected control animal 
as seen in higher magnification showing parasitized 
macrophages Invading the white pulp (H S E 
X 400). 
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Figure 21 : Spleen section from an infected control animal 
as seen in higher magnification, showing numerous 
L,D bodies inside the macrophages (H 5 E X 
1000). 
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Figure 22 : Spleen section from an animal immunized v/ith 
whole antigen and MDP, showing accumula-ion 
of macrophages (H 6 E X 400). 
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Figure 23 : Spleen section In higher magnification showing 
a few Infected macrophages (H S E X 1000). 
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DISCUSSION 
Visceral leishmanial infection in man caused by an 
obligate parasite, Leishmania donovani, has been a subject of 
continued interest and study. The importance of leishmanial 
infection has been fully realised only in the recent years. 
In accordance with the goals of the W.H.O.'s Tropical Disease 
Research Programme, visceral leishmaniasis has been given a 
high priority only next to malaria. Although there is no 
quantitative evaluation at the moment but rough estimates 
based on extrapolations of the scarce data available indicate 
that some 350 million people in the world are at risk for 
acquiring lishmaniasis and that approximately 12 million are 
currently infected (WHO, Tech. Rep. Ser., 1990). Only a few 
experimental attempts have been made to analyze the immune 
aspects of the disease including inununization trials with 
dead or attenuated promastigotes in experimental animals. 
Such attempts were only partially successfull, as no complete 
protection has so far been achieved by the different types of 
vaccine preparations used for this purpose (Lainson & Bray, 
1964; Holbrook and Cook, 1983; Da Costa et al . , 1988). 
Attempts have also been made to confer protection to the host 
by immunization with semi-purified antigens. Glucan used as 
an adjuvant alone, and in combination with leishmanial 
antigens has been reported to confer protection against L. 
donovani in both hamster and mice following a course of 
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immunization (Holbrook et al . , 1981; Cook and Holbrook, 
1982). 
The work done in the present thesis is an extension of 
our previous observations on vaccination studies against L. 
donovani infection. This work further provides the first 
evidence that a certain degree of resistance can be elicited 
against L. donovani by using different leishmanial antigen 
preparations alone, and in combination with Muramyl Dipeptide 
(MDP) as an adjuvant. MDP has already been used as an 
adjuvant in rodent and simian malaria models, conferring 
significant protection against P. berghei and P. knowlesi 
infections. (Khanna et al. , 1990, 1991 ; Khullar and Sehgal, 
1990). The immune enhancement./ stimulation of the host with 
the help of MDP has been assayed and characterized in detail. 
First of all, L. donovani whol antigen was prepared from the 
promastigotes grown in BHMARB medium. The whole antigen 
preparation was further fractionated into soluble and 
particulate antigen fractions. All such preparations were 
partially characterized prior to immunization studies. The 
immunogenicity of each of these antigen preparation, and the 
extent of the protection acheived following their 
administration alone, and in combination with MDP in golden 
hamsters, was thoroughly investigated. The protection 
conferred by these antigen preparations alone, and in 
combination with MDP, was assayed by estimating the humoral 
and cellular immune responses following immunization. The 
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extent of immune protection achieved was studied by-
challenging the animals with viable L. donovani promastigotes 
following immunization. The protection criteria were largely 
based on lowered organ parasite counts, rising antibody 
titres in ELISA and IHA tests and the appearance of delayed 
type hypersensitivity response to leishmanial antigens. 
Haematological and pathological studies were also made to 
support the protection index. 
For the preparation of L. donovani antigens, large 
number of promastigotes free from contaminants are required. 
A number of media have been described by different workers 
for in vitro cultivation of L. donovani promastigotes. But 
earlier studies have shown that only few of these media can 
satisfactorily be used for mass cultivation of L. donovani 
promastigotes, specially for the purpose of antigen isolation 
and for carrying out other immunological studies. In this 
study Brain Heart Infusion Agar with Rabbit Blood (BHMARB) 
was used for mass cultivation and maintenance of L. donovani 
parasites. This medium was found to give satisfactory growth 
of healthy parasite. Each culture tube of BHMARB media was 
inoculated with 1.7 x 10® cells/ml and the highest rate of 
multiplication was obtained at 96 hrs after incubation. In 
BHMARB medium the rate of multiplication was 10.83. The 
results thus obtained were similar to those obtained by 
Jalees et al . (1982). The parasite yield in this study was 
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slightly less than that reported by Jalees et al. (1982). The 
slight decrease in the yield may be due to the limited 
availability of nutrients in the medium and the use of higher 
amount of inoculum at 1.7 x 10® cells/ml, compared to 1x10® 
cells/ml used by the above workers. Thus it is evident that 
higher inoculum resulted in slightly lower parasite yield 
because of insufficient nutrient supply for such a large 
number of parasites. Jalees et al. (1982) also found that 
Hank's Balanced Salt solution (HBSS) with 0.25 per cent 
* 
glucose constitutes a superior overlay medium than the usual 
solution containing 0.1 percent glucose. The additional salts 
present in HBSS were furher shown to help in stimulating the 
growth of promastigotes, thus proving this as a better 
overlay compared to Lock's solution. 
Berens et al. (1976) used HOMEM monophasic, semi 
defined medium for the cultivation of L. donovani 
promastigotes. The maximum multiplication rate was reached 
after 100-120 hours of incubation. Berens and Merr (1978) 
modified the above medium as HOSMEM-II. In this medium the 
stationary phase was attained in 6 days and a 30 fold 
increase in parasitic count was reported. This medium has 
been used for studying nutritional and biosynthetic 
activities of L. donovani and L. braziliensis. Ray and Ghosh 
(1980) used LDLC-II liquid culture medium for mass 
cultivation of L. donovani promastigotes. The maximum growth 
in this medium was on day 13 after incubation; after which 
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the parasite count decreased. Chaudhari et al (1986) used 
another culture medium containing malt extract, 
bacteriological peptone, sodium chloride and hemin (MEP 
medium) for in vitro cultivation of L. donovani 
promastigotes. This medium does not contain blood, serum or 
any other heat-perishable, expensive biological material. The 
maximum rate of multiplication in this medium was achieved at 
120 hrs after incubation. 
Knowledge about the nature of antigenic components of 
parasites, and the antigenic stimulation provided by them, is 
crucial for understanding host-parasite interaction. In the 
case of Leishmania donovani even a partial characterization 
of antigenic components would be useful for effective 
utilization of parasite antigens in serodiagnosis and 
possibly for future use in vaccination experiments. The 
application of newer separation techniques has now made it 
possible to better identify antigens, biochemically and 
immunologically. The various procedures currently in use for 
separating the antigenic components of L. donovani 
promastigotes include centrifugation (El-Amin et al., 1985) 
and sonic disruption (Ghatak et. al., 1982). In the present 
study the whole antigen was prepared by osmolysis of 
promastigotes in double distilled water in accordance with 
the method of Jalees et. al . ( 1 982 ). The soluble and 
particulate antigen fractions were obtained by centrifugation 
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of whole antigen preparation at 105,000 x g for one hour. 
Ghatak et. al. (1982) prepared the whole antigen by 
disintigration for 30 minutes in a disintigrator and further 
fractionated the whole antigen into three subcellular 
fractions by using three successive centrifugations at 4000xg 
for 10 minutes 14,000 x g for 20 minutes and 105,000 x g for 
60 minutes respectively. Cook and Holbrook (1983) used 
alternate freeze and thawing method for obtaining soluble and 
particulate antigen fractions. The preparation was further 
fractionated by sonication, followed by centrifugation at 
11,000 X g for 20 minutes. The L. donovani antigen was also 
prepared by ultrasonication of the parasite suspension. The 
sonicated whole antigen was kept at for two hours and 
then separated into soluble and particulate antigen portions 
by centrifugation at 2000xg for one hour at 4°C . (Rassam and 
Al-Mudhaffar, 1980). White and McMahon (1990) prepared the 
whole antigen by sonication of promastigotes and further 
subjected it to ultracentrifugati on at 100,000 x g for 30 
minutes. The supernatant was later filtered through mi H i pore 
membrane filter to obtain soluble and particulate antigen 
fractions. 
In this study different antigen preparations of L. 
donovani were subjected to biochemical characterization 
mainly for estimating the protein and carbohydrate 
concentrations. The methods employed for characterization of 
antigenic isolates in this study were similar to those used 
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by other workers for determination of protein and 
carbohydrate contents of immunologically active factor of L. 
tropica (Slutzky and Greenblatt, 1979) and of antigenically 
active glycoproteins released by L. donovani (Decker -
Jackson and Honigberg, 1978). The protein - carbohydrate 
ratio in the whole, soluble and particulate antigen fractions 
was 2.10:1, 5.45:1 and 2.85:1 respectively. These results 
clearly suggest that different antigen preparations of L. 
donovani are of both protein and carbohydrate nature. 
Similarly, some other workers suggested a protein -
carbohydrate nature of L. donovani promastigote antigen 
(Ghosh and Roy, 1983). Chaudhari at al . ( 1986) have also 
suggested a protein - carbohydrate nature of L. donovani 
antigen. Many workers have focussed on a carbohydrate rich 
factor which reacted with homologous rabbit antiserum raised 
against promastigotes. These components alternatively 
labelled as excretion factor, exometabolite or antigenically 
active glycoproteins have been used in serotyping of 
leishmanial strains (Schnur et. al., 1972). In SDS - PAGE, 
whole antigen preparation resolved into 4 protein bands in 
molecular weight range of 102.92, 69.78, 41.56 and 26.69 
respectively. The particulate antigen fraction also resolved 
into 4 bands in molecular weight ranges of 87.85, 56.21, 
23.58 and 17.10 respectively. The soluble antigen fraction 
resolved into 2 protein bands in molecular weight range of 
50:88 and 21.16 respectively. Lepay et. al. (1983) showed the 
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presence of three major peptides of 65,000, 25,000 and 
23,000 on the surface of L. donovani. The major antigenic 
determinant of molecular weight 65,000 was recognized as 
glycoprotein and had taken a comparatively deep stain in the 
SDS-PAGE pattern of L. donovani. White and Hanham (1991) 
have shown this glycoprotein to be a common constitutent in 
different species of leishmanias. Dwyer et al (1980) showed 
that a deeply stained band in the SDS-PAGE pattern of L. 
donovani was that of pellicular membrane having a molecular 
weight of about 53,000 daltons. This was also recognized as a 
glycoprotein (Ghosh and Roy, 1983). Ramasamy et. al. (1981) 
also showed the presence of a similar band (53,000 daltons) 
on the outer surface membrane of L. donovani promastigotes. 
The qualitative and immunological behaviour of 
leishmanial antigens against known, clinically positive, 
human sera samples has been studied in agar gel diffusion 
plates (Slutzky and Greenblatt, 1979) and in Indirect 
Flourescent Antibody (IFA) Tests. On qualitative basis all 
the antigen preparations showed well defined precipitin bands 
on agar gel plates. Indirect Haemagglutination (IHA) Test was 
also done for checking the antigenicity of different antigen 
fractions. All the antigen titrations were carried out 
against known positive human sera samples. The use of IHA 
test for diagnostic purposes has also shown promising reuslts 
(Obaid et al., 1989). 
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The earlier concept that adjuvants are necessarily 
aggressive, and, insoluble materials is no longer valid since 
extremely small and simple molecules have been found to be 
equally active. Adjuvants devoid of multiple antigenic 
determinants of whole bactrial cells, the synthetic 
glycopeptides do not elicit the undesirable side effects 
produced by these determinants. These characterstics give 
such adjuvants the potential of becoming useful tools for 
enhancement of immune responses. This point is even more 
crucial while using highly purifed or synthetic vaccines, 
which tend to be weaker immunogens and, therefore, need to 
be combined with a potent adjuvant (Parant , 1980). In this 
thesis efforts have been made to further elaborate the 
activity of Muramyl Dipeptide adjuvant against L. donovani 
infection. Muramyl Dipeptide (N-acetyl - muramyl -L- alanyl -
D- isoglutamine) is the smallest water soluble component of 
the mycobacterial cell wall with adjuvant activity. It is 
the most powerful immuno- adjuvant so far developed and can 
replace the mycobacteria in Freund's complete adjuvant. The 
discovery of MDP has given an impetus to the adjuvant 
research. Extensive studies have been made on the biological 
and immunopharmacological activities of MDP in a number of in 
vivo and in vitro assay systems (Ellouz et. al., 1974; Kotani 
and Watanbe 1 975, Tadaka and Kotani, 1985; Chedid et. al . 
1988). The main biological activities of MDP described by 
various workers are as follows: 
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(1) Adjuvant activity :i.e stimulation of the production of 
antibodies against an antigen injected simultaneously. MDP is 
adjuvant - active even when injected with an antigen in 
saline, either by the same route, or by a different one 
(Audibert et al., 1976). 
(2) Stimulation of non-specific resistance :i.e. against 
bacterial, viral and parasitic injections (Chedid et. al., 
1977; Krahenbuhl et. al., 1981, Ishihara et. al. , 1985) and 
against tumors by stimulation of macrophages (key et. al., 
1982) and N.K. Cells Le Garrec et al., 1985). 
(3) Somnogenic activity : i.e increase of the duration of 
slow wave sleep (Krueger, 1986). 
MDP also incudes other biological responses including: 
transient leucopenia, sensitization to endotoxins, induction 
of granulomas etc. (Masek, 1985). 
The MDP has also shown to enhance antibody response to 
a variety of natural or synthetic antigens even when 
administered only in saline (Chedid et. al . , 1976 ). When 
incorporated into lipsomes, MDP is effective in increasing 
cellular immunity as measured by delayed hypersensitivity, 
without the presence of mineral oils (Masek et. al. , 1978). 
The relationship of the mitogenic activity of MDP to its 
adjuvanticity has been repeatedly investigated. The whole 
in 
mechamsm by which MDP exerts its immunomodulatory effect, 
inspite of extensive research, has not been fully understood. 
In VIVO experiments indicate that T-cells are of paramount 
importance for mediating the stimulatory effects of MDP 
{Lowy et. al . , 1 977 ). Recent studies have shown that MDP 
has a significant value as an immunopotentiator in 
enhancing both non-specific resistance of mice to infection 
with P. berghei - as determined by measuring the number of 
parasites in vaious organs (Khullar and Sehgal, 1990; Khullar 
et. al . , 1988). MDP is also capable of improving the 
efficacy of influenza virus vaccine in mice (Takada et al , 
1977). Protective immunity against malaria was produced in 
Aotus monkeys using MDP and P. falciparum or P. knowlesi 
merozoites (Reese et al . 1 978; Siddiqui et. al . , 1 978). 
Partial immunity to Schistosoma mansoni in rats was produced 
by injecting MDP in the presence of schistosomal antigen 
Tvibously et. al., 1979). Recently, Bhatia et. al. (1990) in 
this laboratory carried out extensive immunization studies 
using MDP with P. knowTesi antigens in rhesus monkeys. The 
protection conferred was satisfactory, these results were in 
accordance with the findings of the earlier workers (Khullar 
et. al., 1985; Reese et. al., 1978). 
In this thesis, the humoral immune responses against 
different leishmania antigens in golden hamsters were 
estimated by using IHA and ELISA tests. ELISA has been found 
more useful and far more sensitive than IFA and 
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immunoelectrophoresis, etc. which were used for the diagnosis 
of Kala-azar (Pearson at al., 1983; Jaffe and Zalis, 1388). 
ELISA technique was first used by Hommel (1976) and 
subsequently by Voller et. al. ( 1976) for the detection of 
anti leishmania antibodies, showing promising results. ELISA 
has also been used by Arora et. al. (1985) in large scale 
seroepidemiological surveys for kala-azar and found it to be 
more practical than IFA. Jalees et al. ( 1982 and 1983) used 
IHA and ELISA for the detection of leishmania antibodies. 
Obaid et al. ( 1989) used ELISA for the detection of humoral 
immune responses during immunization studies against visceral 
leishmaniasis. In this study, elevated antibody titres were 
found in animals immunized with different leishmania antigen 
preparations in combination with MDP. The antibody titre 
values in animals immunized with different leishmania antigen 
preparations only were correspondingly of a lower order. 
Animals immunized with whole antigen in combination with MDP 
exhibited antibody titres. Next to whole antigen, the highest 
antibody titres were obtained from animals immunized with 
particulate antigen fraction and MDP. Our results further 
confirm that MDP in combination with a few antigenic 
fractions is capable of enhancing humoral immune responses 
(Lederer, 1986). MDP and some of its derivatives are 
reported to increase antibody levels when injected in saline 
(Audibert et. al . , 1976). MDP has also been used as an 
adjuvant in guinea pigs, rats and mice using a variety of 
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antigens (Audibert et. a1. , 1976; Tanaka et. al., 1977). MDP 
with saline was shown to be active in mice (Chedid et. al., 
1976; Audibert et. al. , 1976), essentially for stimulating 
the secondary response, Lederer (1986) observed an 
anaphylactic reaction, or even sytemic anaphylaxis, in the 
secondary response of mice preimmunized with MDP. He 
correlated these findings with high levels of IgG, which are 
known to mediate anaphylactic reactions in mice. MDP has been 
successfully used to produce protective immunity in monkeys 
against P. knowlesi infection (Khanna et. al., 1990). 
In vitro cell mediated immune responses (CMI) were 
detected by the development of delayed type hypersensitivity 
responses (DTH) following intradermal antigen inoculation. 
This test has been widely used in studies on the epidemiology 
of Kala-azar in Kenya (Manson-Bahr,1961) and of mucocutaneous 
leishmaniasis in South African countries (Pessoa and Pereira 
Barretto, 1948). The leishmanin test was found slightly more 
specific (Manson-Bahr, 1961). Da costa et. al . ( 1 988) 
reported DTH to have a similar relationship to leishmaniasis 
as that of tuberculin test in tuberculosis, since this test 
measures the delayed hypersensitivity which becomes positive 
soon after the development of cell-mediated immunity. In this 
study footpad swelling in response to animal challenge by 
phenol suspensions of promastigotes was taken as a measure of 
DTH responsiveness. The skin tests in the first week were 
found negative in all the animal groups immunized with 
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found negative in all the animal groups immunized with 
leishmanial antigens alone, and in combination with MDP. Skin 
testing for CMI was carried out in the 2nd, 4th and 6th weeks 
after immunization. Our results show that CMI responses were 
fully manifested in the 2nd week after challenge with viable 
L. donovani promast i gotes. The test was positive only in 
animals immunized with leishmanial antigens in combination 
with MDP. The animals immunized with antigens only, were 
not able to develop such delayed type hypersensitivity 
reactions. The DTH responses were higher in animals 
immunized with whole antigen preparation plus MDP, followed 
by animals receiving particulate antigen fraction plus MDP, 
and animals receiving soluble antigen fraction plus MDP. 
Also, animals immunized with whole antigen preparation 
alongwith MDP showed the maximum macrophage migration 
inhibition (MMI) followed by animals immunized with 
particulate antigen fraction plus MDP. Animals which received 
MDP only were negative in these tests. The results from DTH 
and MMI tests were reproducible and in agreement with one 
another. MDP on administration with antigen was capable of 
inducing delayed type hypersensitivity in guinea pigs 
(Lefrancier and Lederer, 1987). Moreover owl monkeys were 
effectively protected against human malaria parasite after 
immunization with an appropriate antigen in liposomes 
containing MDP (Reese et al., 1978). These finding were 
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rather promising for increasing the cell mediated immunity 
through the use of the technique described above. 
The main immunological feature of visceral 
leishmaniasis is the total suppression of all indicies of 
cellular hypersensitivity to leishmania antigens. This is 
associated with the high parasite multiplication accompanied 
by high levels of specific antibodies and polyclonal IgG and 
IgM (Report of WHO Expert Committee, 1990). Earlier workers 
have suggested from their in vitro experiments that the 
activity may result from interactions with several cell 
types (Parant, 1980). The importance of T-cells as mediators 
for the adjuvant effect of MDP was demonstrated. But MDP was 
also shown to be a direct macrophage activating agent in 
various test systems and capable of inducing the production 
of mediators. However, the absolute requirement of these 
cells in the adjuvant effect is still unknown, since MDP was 
shown to act directly on B-cells (Watson and Whitelock, 
1978). It appears possible that MDP may stimulate all the 
subclasses of lymphocytes by having a strong potential for 
generating a potent adjuvant effect (Watson and Whitlock, 
1978). 
Haldar et. al . (1983) reported the abence of lymphocyte 
blastogenesis to leishmania antigens in an in vitro test. 
Such impairment in eel 1-mediated immunity is attributed to 
the development of suppressor T-cells. However, these cells 
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do not interfere with the activity of helper T-cells which 
alongwith B-cells help in the production of high antibody 
levels (Preston, 1987). Generally speaking, antibodies in 
leishmaniasis are not usually of much critical value in the 
immune protection of the host (Garmham and Humprey, 1969; 
Stauber, 1970). While Zukerman and Lainson (1977) suggested 
that antibodies in leishmaniasis have a limited role in 
providing immune resistance. Our data showed that challenged 
animals which received parasite antigens in combination with 
MDP had raised antibody titres than those given parasite 
antigens alone. Animals immuinized with whole antigen 
preparation in combination with MDP showed raised antibody 
titres, followed by animals immunized with particulate 
antigen fraction plus MDP. 
These results are more or less in agreement with other 
workers who have used BCG, glucan, aluminium hydroxide and 
HES as adjuvants to enhance the immune resistance in mice and 
hamsters against Leishmania donovani infection (Smrkovski and 
Larson, 1977; Jarecki-Black et al. , 1984, 1986, 1988; Obaid 
et. al . , 1989; Cook and Holbrook, 1983 and White and 
McMahan- Pratt, 1990). 
During the course of this study total leukocyte counts 
(TLC) were higher in animals imunized with different 
leishmanial antigens in combination with MDP. This was in 
contrast to the animals which received leishmanial antigens 
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only. Animals immunized with MDP only also showed slight 
changes in TLC values compared to control animals. 
Polymorphonuclear leukocytes were found to be higher in 
animals immunized with leishmanial antigens in combination 
with MDP than the animals immunized with antigen only. The 
elevation in peripheral leukocyte counts may be due to the 
effect of MDP on the haemopoitic system (Yamamura et. al. , 
1981). Earlier workers have reported that mice on treatment 
with MDP showed an overall increase in the production of 
pluripotent stem cells, granulocyte macrophages, pure 
macrophages and erythroid progenitor cells (Saiki et al , 
1981; Chedid and Audibert, 1985). In this study all the 
animals immunized with antigen only, and those of control 
groups, showed leukopenia accompanied with the reduction of 
granulocytes and corresponding increase in lymphocyte and 
monocyte counts. The animals immunized with leishmanial 
antigens in combination with MDP only showed high TLC values 
with little increase in the number of lymphocytes and 
monocyte counts. It has been reported that in kala-azar there 
is a marked reduction in the number of all forms of 
granulocytes leading to leukopenia with relative 
lymphocytosis (Aikat et. al. , 1 979 ; Srivastava et. al . , 
1983). 
The liver and spleen of animals immunized with 
leishmania antigen in combination with MDP after challenge 
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showed a significantly lesser number of parasites compared 
to the animals immunized with antigen alone, and the control 
animals, after challenge. The animals which received whole 
antigen in combination with MDP after challenge showed 
significant reduction in splenic and hepatic parasite counts 
followed by animals immunized with particulate antigen 
fraction alongwith MDP after challenge. Similar results were 
shown by earlier workers who have used BCG, Glucan, 
aluminium hydroxide and HES adjuvants alongwith several 
antigen preparations in mice and hamsters against L. donovani 
infection (Smrkovski and Larson, 1977 Jarecki - Black et. 
al . , 1 984, 1986, 1 988, Obaid et. al. , 1 989; Cook and 
Hoi brook, 1983 and White and McMahon-Pratt, 1990). 
The histopathologic changes in fatal infections of 
Leishmania donovani are characterized by hyperplasia of the 
reticuloendothelial tissue, particularly in Kupffer cells of 
the liver and macrophages of the spleen and bone morrow. This 
condition results in the enlargement of liver and spleen 
tissues accompanied by some circulatory changes (Meleney 
1925, WHO Tech. Rep. Ser., 1984, 1990; Gutierrez et al . , 
1984, Oliveira et al. 1985). Under laboratory conditions, L. 
donovani infects many animal species, some responding in a 
manner similar to that seen in fatal human infections i.e. 
marked macrophage proliferation, and in the formation of 
granulomas in the liver and spleen (Meleney, 1925; Reiner and 
Malemud, 1985, Gutierrez et al., 1984). In the present study 
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control animals infected with L. donovani showed antigenic 
preparations in combination with MDP with little 
splenomegaly. The liver of infected controls showed 
hyperplasia in Kupffer cells with accumulation of macrophages 
forming granulomatous foci. The granuloma formation 
increased with the progress of infection, leading to an 
atrophy of the hepatic cells and distortion of the normal 
liver architecture. A large number of L.D. bodies were seen 
in the hyperplastic macrophages. The results were found to be 
in agreement with those of Meleney (1925) and Gutierrez 
(1984). The animals immunized with leishmanial antigens 
only, there was a greater tendency towards the formation of 
granulomatous foci, hyperlasia of Kupffer cells and atrophy 
of hepatocytes. Stauber (1955, 1966) found different parasite 
growth rates in the liver and spleen of hamsters which 
responded to L. donovani infection, differently. 
The purpose of the present work was to extend the 
previous studies which investigated the effect of Muramyl 
Dipeptide as an adjuvant to enhance the production of 
antibodies, and to stimulate non-specific resistances, in 
particular, to parasitic infections (Lederer, 1986). Taking 
into consideration the powerful immunoadjuvant activity of 
MDP, it was decided to use this adjuvant in vaccination 
experiments using L. donovani antigens. However, no study 
has, so far, sequentially determined the role of MDP against 
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L. donovam infection in hamsters. Although other adjuvants 
such as BCG, glucan, alumimum hydroxide have been found to 
confer higher degree of protection against "leishmaniasis in 
hamsters and mice (Smrkovski and Larson, 1977; Jarecki Black 
et al., 1984, 1986, 1988; Obaid et al . , 1989 and Cook and 
Holbrook, 1983). In this study our observations indicate that 
MDP was able to boost both humoral antibody response as well 
as delayed type hypersensitivity reactions, which were 
comparable with the observations made by earlier workers 
using other adjuvants against L. donovam antigens in 
hamsters. Fairly elevated levels of antibody titres were 
recorded in animals immunized with leishmanial antigens in 
combination with MDP. However, the overall increase in 
humoral immune response was not so critical, since the 
cellular immune responses had been more significantly shown 
to contribute in the mechanism of protection against L. 
donovani infection. The all important role of CMI responses 
was evident from the results on DTH and MMI experiments. The 
protective effect of MDP was not only mediated by macrophages 
but also through an increased number of peripheral leukocytes 
mobilized from bone marrow following the stimulatory effect 
of MDP. The present results are significant with regard to 
the use of MDP as an adjuvant for the development of a safe 
and potent vaccine against L. donovam infection. The 
effectiveness of any immunization procedure will certainly go 
a long way in reducing the permissible doses of 
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also in reducing the accompanying toxic effects of potent 
antileishmanial drugs. Further studies will certainly be 
needed in primates to reassess the adjuvant toxicity, if any, 
before it can be considered for use in humans. 
CONCLUSION 
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CONCLUSION 
The results of this study suggest that Leishmania 
donovani infection is of a synchronous nature and can be 
completely fatal to experimental animals. BHMARB medium was 
satisfactorily used for parasite maintenance to obtain high 
yield of L. donovani promastigotes, which were ultimately 
required for antigen isolation and immunologic studies. 
During these investigations, biochemical and immunological 
tests, were performed to characterize the protein 
carbohydrate nature and the antigenicity of parasite antigens 
used for immunization studies. 
Successful immunization of hamsters against L. donovani 
antigen preparations and MDP was carried out. The different 
parasite antigen fractions alone were not able to generate 
sufficient protective immune responses when injected into 
hamsters. Thus for obtaining protection against L. donovani 
infection, the different parasite antigen fractions were used 
for immunization of hamsters in combination with a potential 
Muramyl Dipeptide adjuvant. In this study animals immunized 
with whole antigen in combination with MDP exhibited maximum 
reciprocal antibody titres. Next to the whole antigen, the 
highest reciprocal antibody titres were obtained from animals 
immunized with particulate antigen fraction and MDP. Our 
results thus demonstrate that MDP in combination with 
antigenic fractions is capable of enhancing humoral immune 
responses. Anti leishmanial antibodies in the immunized 
1S4 
animals were detected by means of IHA and ELISA. These 
results further indicate that ELISA is a more sensitive test 
for evaluation of anti L. donovani antibodies. 
For the detection of cell mediated immune responses to 
leishmania antigens, delayed type hypersensitivity (DTH ) 
tests were used. All the animals immunized with antigens 
alone failed to produce a DTH response before and after 
challenge, while animals immunized with parasite antigen 
fractions in combination with MDP showed positive DTH 
reactions following challenge. The DTH responses were higher 
in animals immunized with whole antigen preparation plus MDP, 
followed by animals receiving soluble antigen fraction plus 
MDP. These observations were based on in vivo testing by 
means of footpad swelling in response to phenol parasite 
suspension, and in vitro by macrophage migration inhibition 
test. 
The haematological studies showed that total leukocytes 
count was higher in animals immunized with leishmanial 
antigens combined with MDP. Following challenge all control 
animals and those which received parasite antigens only 
showed leukopenia accompanied with moderate lymphocytosis and 
monocytosis. The antigen-MDP groups and MDP group of animals 
showed high total leukocyte count with slight increase in 
lymphocytes and monocytes was compared in control animals. 
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The liver and spleen of animals immunized with 
leishmania antigen in combination with MDP after challenge 
showed a significantly lesser number of parasites compared to 
the animals immunized with antigen alone, and the control 
animals, after challenge. The animals which received whole 
antigen in combination with MDP after challenge showed 
significant reduction in splenic and hepatic parasite counts 
followed by animals immunized with particulate antigen 
fraction alongwith MDP after challenge. 
Following challenge with live parasites, the animals 
immunized with whole antigen in combination with MDP showed 
only 60% protection. Thus on the basis of these results it 
was concluded that immunization through intraperitoneal 
route, particularly with the whole antigen in combination 
with MDP, protected the hamsters against a subsequent 
challenge with L. donovani. The immune protection elicited in 
such vaccinated animals was evident by significant reduction 
of parasite counts in the liver and spleen, positive DTH 
responsiveness, high TLC values and almost normal size of 
spleen and liver. These observations, on the basis of above 
studies, demonstrated that MDP alone, or in association with 
antigen enhanced resistance against L. donovani in highly 
vulnerable hamsters. Our studies clearly showed that MDP is 
particularly attractive as an immunotherapeutic agent, as 
also for use as a potential adjuvant in immunoprophylactic 
trials. 
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